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ABSTRACT
Microsporidia Adherence and Infection of Host Cells In Vitro
by
Cory A. Leonard

Microsporidia infect invertebrate and vertebrate animals. Human pathogenic
microsporidia are associated with severe disease in immunocompromised individuals,
and mostly asymptomatic infection in the immunocompetent. Treatment options for
microsporidiosis are limited, incompletely effective, and associated with toxicity.
Furthermore, microsporidia infection of healthy individuals is poorly understood, and the
consequences of asymptomatic infection have not been determined. Little is known
about the molecular mechanisms of microsporidia infection, but such information is
essential for the development of new therapies. Spores adhere to host cell surfaces in
vitro. Our laboratory has focused on determining specific host cell and microsporidia
spore surface participants in spore adherence. Our previous studies have shown that
host cell sulfated glycosaminoglycans and the spore surface protein EnP1 participate in
spore adherence to host cells. Additionally, in vitro inhibition or augmentation of spore
adherence decreased or increased host cell infection, respectively. These studies
demonstrated the importance of spore adherence in host cell infection and began to
characterize the host cell and spore determinants of adherence. The goal of this
research was to further characterize host cell and spore participants in microsporidia
adherence and infection of host cells in vitro. We characterized an intracellular
microsporidia protein and related antibodies for analyses of microsporidia spore surface
proteins; characterized a spore surface protein, MsADAM, involved in spore adherence
to and infection of host cells in vitro; and suggested a role for host cell integrins in
microsporidia adherence to and infection of host cells in vitro.
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CHAPTER 1

INTRODUCTION

Microsporidia and Microsporidiosis
Microsporidia are eukaryotic, obligate intracellular, spore-forming, fungal-related
pathogens that infect a broad range of invertebrate and vertebrate animals, as well as
humans. First described as silkworm pathogens in 1857, microsporidia have long been
known to cause disease in many nonhuman animals including wild and farm raised
animals and domestic pets (Franzen and Müller 2001; Didier et al. 2004; Didier and
Weiss 2006). The first incidence of human microsporidiosis, however, was not
recorded until 1959; and only 10 human cases were reported before the onset of the
human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS)
pandemic (Franzen and Müller 2001; Mathis et al. 2005).
Microsporidia are currently considered to be emerging, opportunistic human
pathogens and are frequently associated with life-threatening diarrhea, wasting, and
disseminated disease in AIDS patients (Franzen and Müller 2001; Didier 2005).
Microsporidia have been found in nearly all organs of the human body and the
symptoms of disseminated microsporidiosis vary by location of the infection. The
clinical syndromes associated with microsporidiosis include enteropathy,
keratoconjunctivitis, sinusitis, tracheobronchitis, encephalitis, interstitial nephritis,
hepatitis, cholecystitis, osteomyelitis, and myositis (Kotler and Orenstein 1998).
Microsporidiosis is not restricted to HIV infected individuals, however, and HIV
negative people with varying degrees of immune deficiency, including those undergoing
solid organ transplant, cancer patients, those with underlying gastrointestinal disease,
diabetics, young children, and the elderly may also exhibit severe or disseminated
forms of the disease (Didier and Weiss 2011; Ditrich et al. 2011; Andreu-Ballester et al.
11

2013). Recently, a study showed 30% prevalence (by polymerase chain reaction; PCR)
of microsporidia in intestinal tissue biopsies from patients with Crohn’s disease, an
inflammatory bowel disease associated with reduced peripheral blood leukocytes; while
no microsporidia DNA was detected in healthy control samples (Andreu-Ballester et al.
2013). In a particularly striking example of severe and disseminated microsporidiosis in
an HIV negative individual, a 57 year old man with no major immune deficiency, under
medical care for diabetes and high blood pressure, suffered a brain abscess attributed
to a microsporidia infection that likely spread to the brain from a primary sinus infection
(Ditrich et al. 2011). Microsporidia thus has the potential to both complicate existing
disease and to cause severe and life-threatening disease in humans without serious
immune deficiency.
Healthy immunocompetent individuals may become infected as well, although
they are typically either asymptomatic or exhibit only mild and self-limiting
gastrointestinal symptoms (Van Gool et al. 1997; Didier and Weiss 2011; Sak, Brady, et
al. 2011; Sak, Kváč, et al. 2011). In a study surveying 576 healthy individuals, high
antibody titers against microsporidia were found in 8% of Dutch blood donors and 5% of
pregnant French women (Van Gool et al. 1997). Another recent study evaluated
samples from 382 healthy Czech residents and showed more directly, by microscopic
stool analysis, 15% prevalence of microsporidia with no significant correlation to
diarrhea (Sak, Brady, et al. 2011). In a smaller study that specifically examined
samples from people with occupational exposure to animals, microscopic and PCR
evaluation of urine and stool samples as well as serological analysis revealed that 14
out of 15 people were positive for microsporidia despite a lack of clinical symptoms
(Sak, Kváč, et al. 2011). These studies suggest that microsporidia infection is relatively
common in healthy individuals and raises the question of asymptomatic carriage in
humans as a potential risk for severe disease in the event of subsequent immune
suppression.
12

Over 1200 species of microsporidia have been identified, and 14 of these have
been shown to infect humans (Didier et al. 2004). Enterocytozoon bieneusi, described
in 1985, is the most common microsporidia to infect humans and the most prevalent
microsporidia in HIV positive individuals (Desportes et al. 1985; Didier et al. 2004; Didier
and Weiss 2011). E. bieneusi rarely causes disseminated disease and is most
frequently associated with self-limiting diarrhea in immunocompetent individuals and
persistent diarrhea and wasting in immunosuppressed individuals (Kotler and Orenstein
1998; Didier et al. 2004). The Encephalitozoon species are also commonly identified in
humans both with and without HIV infection (Didier and Weiss 2011). Although
identification at the species level was not possible at the time, an Encephalitozoon
species was responsible for the first recorded case of human microsporidiosis in 1959
(Mathis et al. 2005).
Encephalitozoon intestinalis is the second most commonly reported cause of
human microsporidiosis, despite its relatively recent description in 1993, and is
frequently associated with HIV/AIDS (Cali et al.1993; Didier et al. 2004; Mathis et al.
2005; Didier and Weiss 2011). Encephalitozoon cuniculi, identified in 1922, was the
first microsporidia to be recognized as a parasite of mammals, and though it is less
frequently identified in humans than E. intestinalis is the best-studied microsporidia and
was the first mammalian microsporidia to be successfully cultured in a laboratory setting
(Smith and Florence 1925; Didier et al. 2004; Mathis et al. 2005; Kotkova et al. 2013).
Both E. intestinalis and E. cuniculi are associated with gastrointestinal symptoms and
disseminated microsporidiosis (Didier et al. 2004; Didier and Weiss 2011). The
remaining 11 species of microsporidia known to infect humans are less frequently
isolated from patients and include Encephalitozoon hellem, Anncaliia algerae, A.
connori, A. vesicularum, Microsporidium africanum, M. ceylonensis, Nosema ocularum,
Pleistophora ronneafiei, Trachipleistophora anthropopthera, T. hominis, and Vittaforma
corneae (Didier and Weiss 2011).
13

Treatment of Microsporidiosis
Treatment of HIV infected individuals with antiretroviral therapy (ART) has greatly
reduced the incidence of opportunistic infections, including microsporidiosis. However,
in areas with insufficient access to ART, diarrhea and wasting associated with
microsporidiosis continue to be a concern (Mathis et al. 2005; Didier and Weiss 2011;
Wumba et al. 2012). Additionally, as stated previously, not all cases of microsporidiosis
are associated with HIV or any immune suppression. Treatment options for
microsporidiosis are extremely limited and are not completely effective. Currently, only
2 drugs are widely used to treat microsporidiosis in humans. Albendazole, a tubulin
polymerization inhibitor with parasitostatic activity, is effective against Encephalitozoon
microsporidia but only variably effective against E. bieneusi (Didier et al. 2004).
Fumagillin, a methionine aminopeptidase-2 (MetAP2) inhibitor that irreversibly blocks
microsporidial MetAP2 and has fungicidal activity, can be used topically to treat
keratoconjunctivitis due to Encephalitozoon species and is effective against E. bieneusi
but causes neutropenia and thrombocytopenia in some patients (Didier et al. 2004;
Anane and Attouchi 2010).
Several additional drugs are being evaluated for treatment of human
microsporidiosis, including TNP-470, a semisynthetic analog of fumagillin, ovalicin,
another MetAP2 inhibitor, fluoroquinolones, topoisomerase IV inhibtors, and polyamine
analogs, which deregulate cell metabolism and inhibit parasite growth (Anane and
Attouchi 2010). A recent study showed that mice experimentally infected with E.
cuniculi then treated with albendazole appeared to clear the parasite, which became
undetectable. Upon subsequent immune suppression, however, the mice exhibited
reactivated infection, suggesting that albendazole treatment may relieve clinical
symptoms but fails to eliminate microsporidial infection (Kotkova et al. 2013). Novel
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more broadly effective and safe therapies are needed to combat the continuing problem
of human microsporidiosis.

Epidemiology and Transmission of Microsporidia
The zoonotic potential of microsporidia is well documented, and contact with wild,
farmed, or domestic animals may be an important risk factor for microsporidiosis
(Deplazes et al. 2000; Didier et al. 2004; Mathis et al. 2005; Słodkowicz-Kowalska
2009). E. cuniculi, first isolated from rabbits, is a particularly important animal pathogen
and frequently infects rabbits, canines, rodents, and monkeys (Smith and Florence
1925; Mathis et al. 2005; Furuya 2009). Recently, a survey of pet dogs in the United
States showed an E. cuniculi seroprevalence rate of 22% in 125 tested serum samples
(Cray and Rivas 2013).
Although E. bieneusi and E. intestinalis were originally isolated from humans,
they are both also capable of infecting nonhuman mammals and E. bieneusi is
frequently detected in birds (Desportes et al. 1985; Cali et al. 1993; Didier and Weiss
2011). Of particular interest is a 2011 study examining stool samples for E. bieneusi
infection and genotype by PCR methods. Two hundred twenty samples taken from
Chinese humans (diarrheal children), pigs, cows, and dogs revealed a 23% E. bieneusi
prevalence in humans, and 16% prevalence in pigs, 8% in dogs, and 38% in cows
(Zhang et al. 2011). Importantly, 5 of the 12 genotypes detected in this study were
found in both humans and animals, strongly suggesting that microsporidia of animal
origin may be infective to humans (Zhang et al. 2011).
A similar study evaluating stool samples from100 pet dogs and 40 pet cats in Iran
showed 31% prevalence for microsporidia in dogs, with 18, 8, and 5 dogs positive for E.
cuniculi, E. bieneusi, and E. intestinalis, respectively. The cats showed 7.5%
prevalence for E. bieneusi alone (Jamshidi et al. 2012). Cases reporting more direct
evidence of zoonotic transmission of microsporidia are rare and limited in sample size.
15

These include a report of a 51 year old AIDS patient with chronic diarrhea and weight
loss and his healthy pet cat testing positive for E. intestinalis by microscopy and PCR,
and 1 child of 3 healthy siblings testing seropositive to E. cuniculi after exposure to
puppies with diagnosed E. cuniculi infection (McInnes and Stewart 1991; Velásquez et
al. 2012). Collectively, these studies provide compelling evidence that animals can
harbor unapparent microsporidia infections and serve as reservoirs for zoonotic
transmission.
Direct human-to-human or animal-to-human transmission of microsporidia is
possible, and animal-to-animal transmission has been confirmed. However, most
human microsporidia infection is thought to occur via inhalation or ingestion of spores
excreted into the environment in feces or urine of infected animals (Didier et al. 2004;
Mathis et al. 2005). While inhalation is probable for pulmonary microsporidiosis in the
absence of gastrointestinal infection, most microsporidiosis is associated with
gastrointestinal infection and it can be assumed that the majority of microsporidia
transmission to humans occurs indirectly via the fecal-oral route. Microsporidia spores
are resistant to temperature and humidity fluctuations and some water treatment
procedures, and they are expected to persist for unknown periods of time in the
environment (Didier et al. 2004; Furuya 2009). Zoonosis likely plays a role in the
contamination of water, and waterfowl have been shown to shed large numbers of
human pathogenic microsporidia spores in their feces (Slodkowicz-Kowalska et al.
2006; Malčeková et al. 2013).
Several studies provide evidence that human pathogenic microsporidia may
contaminate water that humans routinely drink or otherwise come in contact with,
including surface and ground water, water from treatment facilities, and water used for
irrigation of crops (Dowd et al. 1998; Fournier et al. 2000; Thurston-Enriquez et al.
2002). Epidemiological studies support the possibility of waterborne microsporidia
transmission and indicate that exposure to municipal or recreational water sources can
16

be a risk factor for microsporidiosis (Hutin et al. 1998; Cotte et al. 1999). Identification
of microsporidia in water sources contributed to their inclusion on both the National
Institutes of Health Category B list of biodefense pathogens and the Environmental
Protection Agency microbial contaminant candidates list of concern for waterborne
transmission (Didier and Weiss 2006).
Studies indicate that microsporidiosis can also be contracted by ingestion of
contaminated food (Jedrzejewski et al. 2007; Decraene et al. 2012). In 2009, an
outbreak of gastrointestinal microsporidiosis affecting more than 100 people was
caused by a single genotype of E. bieneusi and linked to the consumption of raw,
prewashed cucumbers eaten by conference attendees at a hotel in Sweden (Decraene
et al. 2012). Another recent study in which berries and vegetables purchased in Poland
were evaluated by routine microscopic diagnostic techniques and fluorescent in situ
hybridization (FISH) for speciation showed that E. bieneusi, E. cuniculi, and E.
intestinalis spores can be found on fresh produce intended to be consumed raw
(Jedrzejewski et al. 2007). A similar study conducted in Costa Rica also used
microscopic diagnostics to demonstrate the presence of microsporidia spores on
various berries and vegetables but did not identify the species found (Calvo et al. 2004).
Additionally, E. bieneusi was detected by PCR in 8% of milk samples collected from 180
dairy cows on 45 farms in Korea; genotyping indicated that 20% of the positive samples
were identical to human-infecting E. bieneusi strains (Lee 2008). Thus, food, as well as
water, is a possible source of human infection with microsporidia, and measures for
monitoring and controlling this type of contamination should be considered.
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Spore Structure
The infectious form of microsporidia is the spore, the only extracellularly viable
transmissible form of the organism. The spore wall of microsporidia consists of 2
distinct layers: the proteinaceous exospore, which has a generally uniform surface in
human-infecting microsporidia, and the chitinous endospore, which is of uniform
thickness except at the apex of the spore where the endospore wall thins considerably
(Figure 1.1) (Keeling and Fast 2002). The plasma membrane lies directly adjacent to
the endospore, between the spore wall and the internal contents of the spore, which
include the nucleus, anterior anchoring disk, membranous polaroplast, polar filament,
endoplasmic reticulum, ribosomes, relic mitochondria (mitosomes), and a large
posterior vacuole (Didier and Weiss 2006). The base of the polar filament is associated
with the thin-walled apex of the spore by the anchoring disk. The polar filament,
polaroplast, and posterior vacuole comprise an apparatus for polar tube extrusion that is
unique to the microsporidia.

Figure 1.1 Illustration of a Microsporidia Spore (adapted from Keeling and Fast 2002)
18

Spore Germination
When microsporidia spores are exposed to the appropriate stimuli, the polar
filament is forcibly and rapidly extruded from the thin-walled anterior end of the spore in
a process called germination. The spore ruptures in the vicinity of the anchoring disk
and the polar filament is extruded from the spore, turning inside-out to become the
hollow polar tube (Keeling 2009). The anchoring disk is the attachment point of the
polar tube to the spore, and the infectious spore contents, the sporoplasm, move from
inside the spore, through the polar tube, and exit the distal end of the tube as a droplet
(Xu and Weiss 2005). In an event termed spore activation, various stimuli have been
shown to trigger polar tube extrusion in the lab, including alterations in pH, dehydration
and subsequent rehydration, hyperosmotic conditions, the presence of anions or
cations, ultraviolet exposure, or peroxides (Keeling and Fast 2002; Xu and Weiss 2005).
Regardless of the stimulation that initiates spore activation, germination occurs
due to a rapid influx of water into the spore and an associated swelling of the
polaroplast and posterior vacuole; the pressure from this swelling moves the infectious
sporoplasm into the polar tube and out of the spore, which is essentially reduced to an
empty shell (Figure 1.2) (Keeling and Fast 2002; Xu and Weiss 2005). Several
mechanisms have been suggested for the influx of water into spores during
germination, including an increase in spore permeability to water, degradation of
trehalose to glucose, and displacement of calcium within spore membranes (Pleshinger
and Weidner 1985; Xu and Weiss 2005). The mechanisms for spore activation and
germination in vivo are unknown, but they are likely to differ substantially from
laboratory tested mechanisms, may vary significantly between microsporidia species,
and may depend on host cell type. These mechanisms must occur very rapidly,
however, because spore activation and polar tube eversion takes place in less than 2
seconds (Bigliardi and Sacchi 2001).
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Figure 1.2 Spore Germination. (A) Spore showing the polar filament in black and the
nucleus in gray, the polaroplast at the top of the spore, and the posterior vacuole at the
bottom of the spore. (B) The polaroplast and posterior vacuole swell, the spore ruptures
at the anchoring disk and the polar filament begins to evert. (C) Polar filament continues
to evert, becoming the hollow polar tube. (D) The sporoplasm is forced into the polar
tube. (E) The sporoplasm moves through the polar tube. (F) The sporoplasm emerges
from the polar tube (adapted from Keeling and Fast 2002).
While it is commonly accepted that the force and speed of the everting polar tube
pierces a target host cell’s plasma membrane, allowing direct transfer of the infectious
sporoplasm into the host cell cytoplasm, other mechanisms have been proposed for
host cell infection as well. Microsporidia can be internalized into host cells by
phagocytosis, and Encephalitozoon species were shown to be efficiently internalized by
professional and nonprofessional phagocytes (Couzinet et al. 2000). It has been
suggested that spores might germinate after phagocytic uptake and thus avoid
phagolysosomal digestion (Franzen 2004). It was shown, however, that when
phagocytic E. cuniculi uptake was inhibited by cytochalasin D, an actin polymerization
inhibitor, the number of intracellular replicating E. cuniculi was identical to that found in
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untreated controls, suggesting that polar tube eversion by phagocytosed spores does
not significantly contribute to E. cuniculi infection (Orlik et al. 2010).
Alternatively, according to the “invagination model” of microsporidia host cell
infection, the tip of the polar tube pushes the host cell plasma membrane into the cell
interior forming an invagination; the extruded sporoplasm is injected into this
invagination and part of the host cell plasma membrane pinches off around the
sporoplasm to form a parasitophorous vacuole (PV) in which the microsporidia
subsequently develop (Bohne et al. 2011). This model applies only to microsporidia,
such as the Encephalitozoon species, for which intracellular development takes place
inside a PV, and not to the majority of microsporidia, including Enterocytozoon bieneusi
that develop in direct contact with the host cell cytoplasm. The invagination model of
host cell infection is supported by studies that indicate that the PV in E. cuniculi is
derived from host cell lipids and not the introduced microsporidia sporoplasm
(Rönnebäumer et al. 2008). Although the specific mechanism(s) of microsporidia polar
tube interaction with host cells for sporoplasm transfer remain unclear, the intracellular
development of microsporidia is well described.

Spore Development
After the microsporidia sporoplast is introduced into the host cell cytoplasm,
microsporidia development occurs in 2 main stages: merogony, a replication and
division stage, and sporogony, a differentiation and maturation stage (Keeling and Fast
2002; Williams 2009). Once the sporoplast enters the host cell and begins replication
by fission, the progeny are referred to as a meronts and have a large nuclear region,
minimal organelles and a simple plasma membrane. An electron dense deposition of
material occurs along the plasma membrane as the meronts develop into sporonts. In
microsporidia that develop within PVs, meronts and sporonts can be found adjacent to
the PV membrane (Bigliardi and Sacchi 2001). The final division of sporonts produces
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sporoblasts, the developmental stage in which the spore wall and organelles are
formed. Sporonts become mature spores, as determined by the eventual polarization of
the organelles, and move into the lumen of the PV (Bigliardi and Sacchi 2001). All
stages of spore development can frequently be observed within a single PV (Figure 1.3)
(Mathis et al. 2005).

Figure 1.3 Electron Micrograph of The Developmental Stages of Encephalitozoon
cuniculi in a Parasitophorous Vacuole in In Vitro-cultivated Human Fibroblast Cells. M,
meront; P, sporont; B, sporoblast, with cross sections of the polar tube (indicated by
arrow); S, mature spore (adapted from Mathis et al. 2005).
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Infected cells typically rupture, releasing mature spores, a process that may be
facilitated by specific microsporidia proteins, such as the putative divergent hemolysin
homologue encoded by E. cuniculi (Williams 2009). Interestingly, a recently discovered
nematode pathogenic microsporidia that replicates in direct contact with host cell
cytoplasm appears to be able to “leak” spores from infected epithelial cells by disrupting
the host cell cytoplasm without causing cells lysis, demonstrating that nonlytic infections
may also occur in other non-PV forming microsporidia (Estes et al. 2011). The newly
released mature spores may infect neighboring cells, disseminate within the host, or be
excreted into the environment.

Specific Aims
Microsporidia spores adhere to host cell surfaces in vitro. The molecular events
and processes that determine or result from this adherence are poorly understood.
Previous studies showed the adherence process was mediated in part by host cell
surface sulfated glycosaminoglycans (GAGs) and the microsporidia spore wall protein
EnP1 (Hayman et al. 2005; Southern et al. 2007). Importantly, when microsporidia
adherence to host cells was inhibited by adding exogenous sulfated GAGs or
recombinant EnP1 to adherence assays, host cell infection was also reduced (Hayman
et al. 2005; Southern et al. 2007). In another previous study, the addition of magnesium
or manganese divalent cations to adherence assays increased spore adherence,
resulting in a correlating increased host cell infection (Southern, Jolly, and Hayman
2006). These data shape our hypothesis that spore adherence is an integral event in
microsporidia infection of host cells in vitro. Complete ablation of spore adherence and
infection was not achieved using exogenous sulfated GAGs or recombinant EnP1,
however, indicating that additional spore and/or host cell determinants of adherence
and infection may exist.
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The goal of this research is to identify host cell and spore participants in
microsporidia adherence and infection of host cells in vitro. The specific aims of these
studies are to i) characterize an intracellular microsporidia protein and related
antibodies to use in comparative analyses of microsporidia spore surface proteins, ii)
identify putative microsporidia spore surface proteins that participate in spore
adherence to and infection of host cells in vitro, and iii) examine the role of host cell
integrins in microsporidia adherence to and infection of host cells in vitro.
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Abstract
Microsporidia spore surface proteins are an important, under investigated aspect
of spore/host cell attachment and infection. For comparison analysis of surface
proteins, we required antibody specific for an intracellular protein. An endoplasmic
reticulum associated heat shock protein 70 family member (Hsp70; ECU02_0100; ‘C1’)
was chosen for further analysis. DNA encoding the C1 hsp70 was amplified, cloned
and used to heterologously express the C1 Hsp70 protein, and specific antiserum was
generated. Two-dimensional Western blotting analysis showed that the purified
antibodies were monospecific. Immuno-electron microscopy of developing and mature
E. cuniculi spores revealed that the protein localized to internal structures and not to the
spore surface. In spore adherence inhibition assays, the anti-C1 antibodies did not
inhibit spore adherence to host cell surfaces, whereas antibodies to a known surface
adhesin (EnP1) did. In future studies, the antibodies to the ‘C1’ Hsp70 will be used to
delineate spore surface protein expression.
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Introduction
Microsporidia are spore-forming, obligate intracellular divergent fungi with an
extensive host range that includes most vertebrates and invertebrates. Although the
first species of microsporidia was described over 150 years ago, microsporidiosis was
rarely diagnosed in humans prior to the AIDS pandemic. Today, microsporidia are
recognized as opportunistic pathogens of humans [1]. Most microsporidia infections in
humans are thought to arise via the fecal-oral route. Ingestion of the environmentally
stable spores leads to primary infection in the small intestine where replication of the
organisms results in destruction of the epithelium. Therefore, the most common clinical
manifestations of microsporidiosis are self-limiting diarrhea in immunocompetent
individuals and persistent diarrhea perhaps leading to a wasting syndrome in the
immunocompromised [2].

All microsporidia possess a unique invasion apparatus known as the polar tube
or polar filament, which must be discharged in order to infect the host cell. Upon
extrusion, the polar tube penetrates the host cell plasma membrane and allows the
passage of infectious sporoplasm from the spore through the hollow polar tube into the
host cell cytoplasm where replication occurs. We hypothesize that infection of the host
cell is facilitated by adherence of the microsporidia spore to the host cell surface prior to
or during the activation process. Our previous studies have demonstrated that
microsporidia spores of the genus Encephalitozoon adhere to the host cell surface in
vitro through at least one mechanism involving host cell glycosaminoglycans [3]. In vitro
spore adherence and host cell infectivity assays demonstrate that addition of
exogenous sulfated glycosaminoglycans to the culture medium results in decreased
spore adherence and decreased number of infected host cells. Our studies indicate a
direct association between microsporidia adherence to the host cell surface and
infectivity.
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To understand the mechanism of microsporidia adherence, we have turned our
attention to identifying possible ligands on the spore surface. We are searching the
Encephalitozoon cuniculi genome database for genes that encode proteins with
recognizable adhesion domains. Identified proteins are recombinantly expressed,
purified, and used for antibody production. We are using previously developed assays
to evaluate the recombinant proteins and their corresponding antibodies as potential
inhibitors of spore adherence and/or host cell infectivity. For comparison purposes, we
require a microsporidia protein that is not located on the spore surface and does not
inhibit spore adherence or infectivity. Because heat shock proteins (Hsps) are typically
found in the cytosol, ER, and mitochondria of a cell [4], we chose to examine the
Hsp70-related proteins from E. cuniculi as potential candidates. In this study, we
demonstrate by transmission immunoelectron microscopy that the Hsp70-related
protein (ECU02_0100) is located in internal structures of the spore. We also show that
antibodies against the recombinant Hsp70-related protein C1 do not significantly inhibit
spore adherence or host cell infection in vitro. Recombinant Hsp70 protein and the
antibodies against this protein will be used for comparative purposes in our quest to
identify possible microsporidia spore ligands that function during adherence.

Materials and Methods
Microsporidia and Host Cell Cultivation
African green monkey kidney cells (Vero; ATCC CCL-81) and rabbit kidney cells
(RK-13; ATCC CCL-37) were used for the cultivation of microsporidia spores. Adherent
cells were maintained in Dulbecco’s modified Eagle’s medium (BioWhittaker,
Walkersville, MD) supplemented with L-glutamine (2 mM), penicillin (100 U/ml),
streptomycin (100 µg/ml), amphotericin B (0.25 µm/ml), and 2% fetal bovine serum
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(BioWhittaker) in 5% CO2 at 37oC. Microsporidia spore propagation and purification
were performed as previously described [5].

Recombinant Protein Expression and Antiserum Production
The gene encoding the “C1” Hsp70-related protein (ECU02_0100) was PCR
amplified from E. cuniculi genomic DNA using the following primers; 5’GGAATTCATGAACAAGGGTATGCTAG-3’ and 5’ACTCGAGGAGTTCTTCTCTCCCTATTTC-3’. The amplicon was cloned into the
pET21a vector (EMD Biosciences, Inc., Madison, WI) using restriction endonucleases
and ligation. Following transformation into Escherichia coli Rosetta Gami cells (EMD
Biosciences) and induction with IPTG (isopropyl--D-thiogalactopyranoside), the
bacterial harvest was sonicated in PBS containing 5% SDS and 2% -mercaptoethanol.
SDS-PAGE gels were Coomassie stained, and Western analysis was performed using
a histidine-tag-specific antibody (Sigma-Aldrich, St. Louis, MO) to confirm recombinant
protein expression.

For purification, the bacterial pellet was sonicated in column chromatography
binding buffer containing 8 M urea and 20 mM imidazole in 1X phosphate buffer saline.
The supernatant was applied to an equilibrated nickel affinity column (GE Biosciences,
Piscataway, NJ). Following washes with binding buffer, the recombinant protein was
eluted with 1X phosphate buffer saline containing 8 M urea and 300 mM imidazole.
Fractions containing recombinant protein were combined and dialyzed against 10 mM
Tris buffer (pH 7.4) with 0.5 mM EDTA. The resulting dialysate was centrifuged, and
the supernatant containing the protein was pooled and stored at -20oC for further use.

For antiserum production, naïve rabbits were immunized with the recombinant
C1 Hsp70-related protein using a 56-day immunization protocol conducted at a
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commercial facility (Proteintech Group, Inc., Chicago, IL). Antibodies from both preand post-immunized rabbits were purified from serum using protein A/G affinity
chromatography according to the manufacturer’s recommendations (Thermo Fisher
Scientific, Rockford, IL).

Spore Adherence Assays
Microsporidia spore adherence assays were performed as previously described
[3]. RK13 cells were seeded onto round glass coverslips in 12-well plates and grown to
confluence. To test adherence, purified diluted anti-C1 antibodies (1 mg/ml) or antiEnP1 antibodies (1 mg/ml) [6] were incubated with E. cuniculi spores in medium on
RK13 host cells for 4-hours on ice. The unbound spores were removed by washing with
PBS, and the bound spores were quantified by immunofluorescence as described [6].
The results are expressed as the percentage of adherent spores relative to control
samples. Statistical significance was determined using the Student’s t test.

SDS-PAGE Analysis and Western Blotting
One-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (1DSDS-PAGE) was performed with purified spore protein as previously described [6]. For
two-dimensional (2D) SDS-PAGE analysis, 1 x 109 purified E. cuniculi spores were used
for protein sample preparation following the procedures and buffers recommended in
the ReadyPrep 2D-Starter Kit (Biorad; Hercules, CA) with slight modifications. The
spore pellet was digested for 30 minutes at boiling temperature in denaturing buffer
containing 0.05% SDS and 0.1% 2-mercaptoethanol. The supernatant was transferred
to a new tube, and the free SDS was removed using the SDS-Out Reagent
(Pierce/Thermo Scientific; Rockford, IL). The buffer was exchanged for the
ReadyPrep2D Rehydration/Sample buffer using a Microcon (YM-10) Centrifugal Filter
Device (Millipore; Billerica, MA). The buffer volume equivalent of 2.5 x 10 8 spores was
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used to rehydrate two 11 cm pH 4-7 IPG strips according to the ReadyStrip IPG
protocol (Biorad). The strips were focused using a Biorad Protean IEF cell and the
standard recommendations for programming. For the second dimension, the gel strips
were equilibrated in the kit Equilibration Buffer I and II and pre-cast Criterion 8-16%
Tris-HCl SDS-PAGE gels (Biorad) were used. For Western blots, the gels were
transferred as described [6].

To identify the Hsp70-related proteins, gel spots from Coomassie stained 2DSDS-PAGE gels were excised and submitted for commercial protein identification by
trypsin digestion and tandem mass spectrometry using nano-liquid
chromatography/tandem mass spectrometry (Midwest Bio Services, Overland Park,
KS). The acquired data were analyzed using Sequest database searching software.

Results
Cloning and Heterologous Expression of E. cuniculi Recombinant Hsp70-related Protein
To identify an internal protein for comparison to spore surface proteins, we
focused on heat-shock proteins (Hsp), which are usually located internally in the
cytosol, endoplasmic reticulum, or mitochondria. Analysis of the E. cuniculi genome
database revealed several candidate Hsp70-related genes, some of which have been
characterized including the canonical mitochondrial organellar heat shock protein [7-9].
However, for our purposes, we selected a highly expressed Hsp70 family member from
E. cuniculi (ECU02_0100; ‘C1’), which contains all three Hsp70 protein family signature
motifs of conserved family members identified by Prosite database scanning [10]. In
addition, this protein contains an N-terminal signal peptide allowing it to be translocated
into the endoplasmic reticulum (ER) and a C-terminal ER targeting sequence (“REEL”),
which would retain the protein in the ER.
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The open reading frame that encodes from the N-terminal methionine residue to
the C-terminal leucine residue immediately prior to the termination codon of C1 was
amplified, cloned, and expressed in E. coli. The expressed recombinant protein was
similar to the predicted size of 76.2 kDa (Figure 2.1A) and was used to immunize naïve
rabbits. In one-dimensional Western blot analysis using purified spore protein from both
E. intestinalis and E. cuniculi, the anti-C1 Hsp70 protein antibodies recognized a single
protein band from both species (Figure 2.1B). However, our analysis of the E. cuniculi
genome database identified a second Hsp70-related protein with a predicted size of
74.8 kDa (ECU03_0520; ‘B1’). Because the masses of these two proteins are so
similar and the predicted amino acid identity is 28.3%, the single band observed in 1D
Westerns may represent recognition of both the C1 and B1 Hsps. Such reactivity would
be difficult to distinguish using one-dimensional SDS-PAGE. Therefore, twodimensional SDS-PAGE electrophoresis and Western blotting analysis were performed
with purified E. cuniculi spore proteins and the anti-C1 Hsp70 antibodies. Matrixassisted laser desorption ionization mass spectrometry analysis of trypsin digested
Coomassie gel spots identified both the C1 and B1 Hsp70 proteins (Figure 2.1C).
Peptide coverage represented 38 and 24% of the C1 and B1 proteins, respectively.
Interestingly, the B1 protein, which is predicted to be 74.8 kDa, is slightly larger in mass
on the 2D SDS-PAGE gel than the predicted 76.2 kDa C1 protein. It is possible that the
removal of the signal peptide from the C1 could account for the size discrepancy.
Nonetheless, Western blotting of the two dimensional SDS-PAGE shows that the antiC1 Hsp70 antibodies are specific for the C1 Hsp70-related protein and do not cross
react with the similar sized B1 protein (Figure 2.1D).
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Figure 2.1 Heterologous Expression of E. cuniculi C1 Hsp70 Protein as a Histidine
Fusion Protein in E. coli and Western Blot Analysis Using Purified C1 Antibodies. A
Coomassie stain SDS-PAGE gel (A, right panel) of uninduced and IPTG induced
expression of the recombinant protein shows a ~76 kDa protein in the induced lane. A
Western blot of the SDS-PAGE gel was performed using histidine-tag-specific
antibodies (A, left panel) confirmed the recombinant protein induction. (B) A single ~76
kDa band was detected on 1D Western blot of E. cuniculi and E. intestinalis total spore
protein using a purified C1 Hsp70 protein antibodies. (C) The C1 (ECU02_0100) and
B1 (ECU03_0520) Hsp70-related proteins were identified from a Coomassie stained 2D
SDS-PAGE gel of E. cuniculi total spore protein by MALDI-MS analysis of trypsin
digested gel spots. (D) Western analysis of the 2D gel using the C1 specific antibodies
detected only the C1 protein (D).
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Immuno-localization of C1 Hsp70-like Protein in E. cuniculi Spores
To confirm that the C1 Hsp70-like protein does not localize to the spore wall,
immuno-gold labeled transmission electron microscopy (immuno-TEM) of E. cuniculi
infected RK13 cells was performed using the purified anti-C1 Hsp70 antibodies. The
antibodies recognize protein in both immature (Figure 2.2A), and mature spores (Figure
2.2B). The C1 Hsp70 protein does not appear to be located in one specific area, but
rather is spread throughout the cytoplasm. In microsporidia, the membranous ER and
associated ribosomes of spores is difficult to visualize, especially in immuno-localization
TEM resin. However, in structural studies, the ER has been located both surrounding
the nucleus and in other parts of the cytoplasm [11]. The immuno-labeling of the C1
Hsp70 protein in Figure 2 appears to match the ER structural profile. No significant
immuno-labeling was evident on the outside surfaces of developing or mature spores or
within host cells that did not contain parasitophorous vacuoles (data not shown).

A
PTC

N

B
PTC

PTC
PV

AD
PTC

500nm

500nm

Figure 2.2 Immuno-TEM of E. cuniculi Infected Rabbit Kidney Cells. The infected cells
were prepared according to the protocol described. Ultrathin Lowicryl resin sections
were cut and reacted with C1 Hsp70 specific antibodies (1:10) and a secondary
antibody conjugated to 15-nm gold particles (1:200). The developmental stages include
immature meronts and sporonts (the lower and upper spores in “A”, respectively) and
mature spore (B). Abbreviations are as follows: PTC, polar tube coil; N, nucleus; PV,
posterior vacuole; AD, anchoring disk. Each bar indicates a 500-nm scale.
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Anti-C1 Antibodies do Not Inhibit E. cuniculi Spore Adherence to Host Cells
Previous studies have shown that microsporidia infection of host cells may
involve an initial attachment of spores to host cell surfaces, which precedes spore
activation, germination, and polar filament extrusion [3, 6]. Spore attachment, and thus
host cell infection, can be inhibited with the addition of either sulfated
glycosaminoglycans, a common host cell surface glycan, or exogenous endospore
protein-1 (EnP1). EnP1 is found in both the endospore and exospore regions of spore
walls and is an adherence ligand potentially involved in the spore activation process [6,
12]. Addition of either recombinant EnP1 or anti-EnP1 antibodies to spore adherence
assays significantly reduces the number of adherent spores. To confirm that the antiC1 Hsp70 antibodies, which specifically recognize the non-surface associated ER
Hsp70 protein, do not affect spore attachment, spore/host cell adherence assays were
performed using both the anti-C1 antibodies and the anti-EnP1 antibodies (Figure 2.3).
Adding increasing amounts of anti-EnP1 antibodies leads to dose-dependent decreases
in spore adherence, as was expected. However, equivalent quantities of anti-C1
antibodies have no effect on spore adherence to host cell surfaces, confirming that the
internally located C1 Hsp70 is not involved in adherence.

Discussion
Previous studies involving Hsp70 proteins of microsporidia have revolved around
phylogeny, in part due to the fact that microsporidia are “amitochondriate” organisms [79, 13]. During microsporidia genome sequencing efforts, a mitochondria-associated
heat shock protein was identified, despite the fact that microsporidia have no identifiable
mitochondria organelle. Studies involving this Hsp eventually identified an “ancient”
mitochondria organelle called a mitosome [9, 14]. This discovery placed microsporidia
in a small group of amitochondriates, which includes Giardia intestinalis, Trichomonas
vaginalis, and Entamoeba histolytica [14, 15]. Further studies revealed that several
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iron-sulphur cluster assembly proteins were located in the mitosome based on their colocalization with the mitosome-associated Hsp70 family member [16].
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Figure 2.3 Purified Antibodies Specific for the Internal C1 Hsp70 Protein do Not Inhibit
E. cuniculi Spore Adherence to Rabbit Kidney Host Cells. Increasing concentrations of
C1 antibodies (open circles) or EnP1 specific antibodies (open triangle) were incubated
with spores in the presence of confluent host cells. Control samples excluded
antibodies. After 4-hours, unbound spores were removed by washing and the bound
spores were quantified by immunofluorescence assay. Each antibody dilution sample
was performed in triplicate. Statistical significance is indicated with asterisks (P <
0.0001).
Most cells have multiple members of the Hsp70 family of heat shock proteins that
function in a variety of manners. The most recognized functions of Hsp70s are to assist
in protein folding and trafficking and coping with protein denaturation in response to
increased stress, such as heat [4]. Interestingly, studies have shown that within the cell,
Hsp70 family members may also exert a pro-survival affect, combating the intrinsic
apoptotic pathway activation in neuronal cells [17]. Hsp72 inhibits the release of
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cytochrome-c from the mitochondria, inhibits apoptosis inducing factor translocation to
the nucleus, and interferes with recruitment of procaspase-9 into the apoptosome [18].
Recently, it has also been shown that some Hsp70 family members can be released
from cells to serve as a physiological alarm signal for cell trauma or to act as pro- or
anti-inflammatory mediators [19-21]. Either through active transport or passive release
due to cellular destruction, the released Hsp proteins exert their affect beyond the cell
from which they originated. In our immuno-TEM analysis, we did not see significant
labeling in any host cell organelle. Nor, was there significant labeling in the extracellular
spaces within the parasitophorous vacuole indicating that the ER associated Hsp70-like
protein may not be secreted. It remains to be seen whether the E. cuniculi cytosolic
Hsp70-related protein (ECU03_0520; B1), which does not contain an ER retention
signal or a signal peptide, is released from developing or mature spores.

The C1 Hsp70 protein contains an ER retention signal at the C-terminal end.
Although the ER has not been extensively studied in microsporidia, structural studies
have identified the ER as membranous elements arranged in parallel cisternae covered
by ribosomes [11]. These elements both surround the nucleus and are dispersed
throughout the cytoplasm. Both the spore-wall and polar-tube proteins have predicted
signal peptides for ER translocation and trafficking [22-24]. Recent studies indicate that
microsporidia have the necessary machinery, albeit reduced and modified, for
translocation of polypeptide chains into the ER [25]. Furthermore, Golgi complex
studies in microsporidia suggest they do not create budding vesicles with typical
eukaryotic coat proteins, but have instead tubular networks that directly connect to the
ER, the polar tube membrane, and the plasma membrane [26]. Thus, the extensive
network of membranes would be distributed throughout the spore cytoplasm. The
varied immuno-EM cytosolic labeling of C1 Hsp70 protein shown here would be
indicative of an extensive membranous ER/Golgi secretory pathway.
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In summary, we have cloned and expressed an ER associated member of the
Hsp70 family from E. cuniculi. Antibodies generated against this protein specifically
recognize C1 Hsp70 from microsporidia and localize it to internal structures of spores.
Moreover, the anti-C1 antibodies did not inhibit spore adherence. As a result, the C1
Hsp70 protein and the antibody are important tools for research in the field of
microsporidia and will be used as internal markers for comparisons during our studies
on spore adherence.
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Abstract
Microsporidia spore adherence is a mechanism that modulates host cell infection
in vitro. To better understand adherence, we focused on determining which
microsporidia proteins are involved in this process. Examination of the Encephalitozoon
cuniculi genome database revealed a gene that encodes a protein with sequence
homology to members of the ADAM (a disintegrin and metalloprotease) family of type I
transmembrane glycoproteins. ADAM proteins are involved in a variety of biological
processes including cell adhesion and proteolysis. Like other ADAM family members,
the microsporidia ADAM protein (MsADAM) has a putative signal peptide, a pro-domain,
a metalloprotease domain, a disintegrin domain, and a transmembrane domain.
Immunoelectron microscopy of host cells infected in vitro with E. cuniculi and E.
intestinalis demonstrates that MsADAM localizes to the plasma membrane, exospore
and polar sac-anchoring disk regions of E. intestinalis spores and to the polar sacanchoring disk complex of E. cuniculi spores. Addition of exogenous MsADAM reduces
adherence and infection of E. intestinalis, but not E. cuniculi. These data suggest a
species-specific role for MsADAM in the adherence and infection process.
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Introduction
Microsporidia are spore-forming, obligate intracellular, fungal-related parasites
that have a broad host range encompassing most invertebrates and vertebrates,
including humans. Environmentally, microsporidia are typically found in water sources
and owe their survival to the rigid external spore wall, which consists of three layers: the
external proteinaceous exospore, the protective chitinous endospore, and an inner
plasma membrane. Ingestion of spores may lead to primary infection of the
gastrointestinal tract, resulting in intestinal cell sloughing and persistent diarrhea in
immunocompromised humans, particularly those infected with human immunodeficiency
virus (HIV) [1]. Some microsporidia species, including the Encephalitozoon species,
can disseminate to other organs from the gastrointestinal system [2]. Furthermore,
microsporidia infections have been documented in immunocompetent humans,
including travelers and contact lens users [3,4].
Microsporidia infect cells via a unique process involving extrusion of a hollow
polar filament (or tube) from a coiled position within the spore. In response to an
undefined stimulus in the gastrointestinal tract, the spore forcibly extrudes the polar
tube, which pierces, or is taken in through, the host cell membrane. The contents of the
spore are then transferred via the polar tube into the host cell cytoplasm. Following
infection of the host cell, spore propagation and development result in host cell rupture
and release of mature spores into the intestinal lumen. These mature spores may infect
nearby cells, disseminate to other organ systems, or be excreted from the body into the
environment.
Spores adhere to host cell surfaces in vitro. In previous studies, we have shown
that the adherence process is mediated in part by host cell surface sulfated
glycosaminoglycans (GAGs) [5]. Spore adherence was inhibited by the addition of
exogenous GAGs to cell culture media in in vitro assays for microsporidia host cell
adherence and was also significantly reduced in GAG deficient host cells, compared to
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host cells with normal GAG expression. Importantly, when adherence was inhibited,
host cell infection was also reduced. In other studies, we have shown that the addition
of magnesium or manganese divalent cations during application of microsporidia to host
cells augments spore adherence, resulting in a correlating increased host cell infection
[6]. These data shape our hypothesis that spore adherence is an integral event in the
infection of host cells by microsporidia.
To better understand the mechanism of adherence, we have focused on
determining which host and microsporidia proteins are involved in adherence.
Previously we have shown that a microsporidia spore surface protein EnP1 participates
in microsporidia adherence and infection of host cells [7,8]. However, complete ablation
of spore adherence to host cells was not achieved using exogenous EnP1 as an
inhibitor of adherence and infection, suggesting that additional or alternative spore
determinants of host cell adherence and infection may exist. Examination of the
Encephalitozoon cuniculi genome database for putative adherence proteins revealed a
gene encoding a protein with sequence homology to members of the ADAM (a
disintegrin and metalloprotease) family. ADAMs are type I transmembrane proteins with
multiple domains responsible for several physiological functions, including proteolysis,
adhesion, fusion, and signaling. These domains include a pro-domain, a
metalloprotease domain, a disintegrin-like domain, a cysteine-rich domain, an EGF-like
domain, a transmembrane domain, and cytoplasmic domains (Figure 3.1).
Approximately half of the 40 known ADAM family members contain an apparently
functional catalytic consensus sequence (HEXXHXXGXXH) in their metalloprotease
domains. Active metalloprotease domains are responsible for the cleavage of cell
surface molecules on the same cell [9] or neighboring cells [10]. One of the most
studied ADAM cleavage targets is tumor necrosis factor-, which is released from the
cell surface by the tumor-necrosis-factor-converting enzyme (TACE; ADAM 17) [11,12].
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The disintegrin domains of ADAMs are homologous to snake venom disintegrins
and associate with integrins. ADAM 15, for example, can bind several integrins in both
an RGD dependent (v3) [13] and independent (91) [14] manner. In addition,
ADAMs 2 and 3 may participate in sperm-egg binding by interacting with integrin
molecules on the surface of eggs [15]. This interaction may involve a specific region of
the disintegrin domain called the integrin binding loop [16]. However, this loop is not the
sole region responsible for target specificity, and the cysteine-rich domain is also
important in cell adhesion [17,18].
Functional assays suggest the presence of proteases in microsporidia.
Examination of soluble extracts from immature spores revealed four prominent protein
bands on zymograms, two of which were identified as aminopeptidases [19]. Based on
azocasein assays including various ions, these studies also predicted the presence of
metallopeptidases in microsporidia [19]. The possible presence of protease activity or
integrin binding activity in the microsporidia ADAM family protein suggests that this type
of protein might play a role in host cell adherence and infection. In this study, we
characterize a novel microsporidia ADAM family member (microsporidia ADAM,
MsADAM) by examining the sequence characteristics and localization of MsADAM in E.
intestinalis and E. cuniculi spores. Our results show that in E. intestinalis spores,
MsADAM is located both at the spore surface and in other structures inside the spore.
In E. cuniculi spores, however, MsADAM is absent from the spore surface and is
expressed only in internal spore structures. Importantly, the addition of exogenous
recombinant MsADAM to assays of spore adherence reduced adherence of E.
intestinalis spores, but not E. cuniculi spores, to host cells. The MsADAM-dependent
inhibition of adherence of E. intestinalis spores resulted in a reduction of host cell
infection, suggesting a species-specific role for MsADAM in the microsporidia
adherence and infection process.
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Materials and Methods
Microsporidia Propagation and Purification
E. cuniculi and E. intestinalis were propagated in rabbit kidney cells (RK-13;
ATCC CCL-37) or African green monkey kidney cells (Vero; ATCC CCL-81) as
previously described [20]. Briefly, subconfluent RK-13 or Vero monolayers grown in 75
cm2 tissue culture flasks were incubated with either E. cuniculi (RK-13 cells) or E.
intestinalis spores (Vero cells) for 10-12 days with growth medium replacement as
needed. Cultures were maintained in 5% CO2 at 37oC in growth medium consisting of
Dulbecco’s modified Eagle’s medium (BioWhittaker; Walkersville, MD) supplemented
with L-glutamine (2 mM), penicillin (100 U ml-1), streptomycin (100 U ml-1), Amphotericin
B (0.25 mcg ml-1), and 2% fetal bovine serum. After collection of infected host cells
debris in growth medium, spores were harvested by centrifugation at 3500 RPM for 10
minutes and purified from the host cell debris by washing with 0.25% sodium dodecyl
sulfate (SDS) followed by several washes in sterile water. Spores were counted and
stored in sterile water at 4C.

MsADAM Sequence Comparisons to ADAM Family Members
Sequence identities were determined by global pairwise alignment of both whole
protein sequences from ADAM family members and each individual domain sequence
independently using the LALIGN program [21].

Cloning and Recombinant Protein Expression
DNA encoding the region from the pro-domain to the transmembrane-domain of
MsADAM (amino acids 21-527), the MsADAM pro-domain (amino acids 21-137), and
the MsADAM metalloprotease domain (amino acids 140-362) was amplified by PCR
using genomic DNA from E. cuniculi infected RK-13 cells and the following
oligonucleotide primers: MsADAM pro-domain to transmembrane domain (5’47

GGAATTCTTCACTGACCCGGATGGTAAG-3’ and 5’ACTCGAGTGTAGCTGCTGAATTGCTGTCTC-3’), MsADAM pro-domain (5’GGAATTCTTCACTGACCCGGATGGTAAG-3’ and “5’GTACTCGAGGACGTTTCCCCTCCTCATC-3’), and MsADAM metalloprotease domain
(5’-GGAATTCACAAGAGTCATCAAAGTG-3’ and 5’GTACTCGAGTATCTCGCCAAATTTGGATTC-3’).
The resulting PCR products were individually cloned into the pET-21a vector
(Novagen; San Diego, CA), which places a histidine tag on the terminal end of the
recombinant proteins. Escherichia coli XL1-Blue (Stratagene; La Jolla, CA) was used
as the host strain for plasmid propagation. After verifying the DNA sequence, the
plasmid was transformed into E. coli Rosetta-gami cells for protein expression (EMD
Chemicals, Inc.; San Diego, CA). Recombinant protein expression was induced by
addition of 1 mM isopropyl--D-thiogalactopyranoside (IPTG) to the culture for 4 hours
at 37C with shaking. Following induction, bacteria were harvested, resuspended in
binding buffer (1X phosphate buffer pH 7.4, 20 mM Imidazole, and 8 M urea) and lysed
by sonication. Protein lysates from induced and non-induced bacteria cultures were
separated by sodium lauryl dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) and compared via Coomassie Brilliant Blue R staining (Sigma-Aldrich; St. Louis,
MO) or transferred to nitrocellulose membrane for Western analyses of expression of
the histidine-tagged recombinant MsADAM protein (rMsADAM; amino acids 21-527),
MsADAM pro-domain (rPRO; amino acids 21-137) and MsADAM metalloprotease
domain (rMET; amino acids 140-362). Western analyses were conducted using a 1:500
dilution of mouse monoclonal anti-polyhistidine antibody (Sigma-Aldrich; St. Louis, MO),
and a 1:2000 dilution of rabbit anti-mouse alkaline phosphatase-conjugated antibody
(Southern Biotech; Birmingham, AL). BCIP (5-bromo-4-chloro-3'-indolyphosphate ptoluidine salt) and NBT (nitro-blue tetrazolium chloride) were used for detection.
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Recombinant Protein Purification and Antibody Production
Nickel affinity chromatography purification of histidine-tagged rMsADAM, rPRO,
and rMET from E. coli was performed according to the manufacturer’s protocol using
HiTrap HP (GE Healthcare; Piscataway, NJ) chromatography. Elution fractions of each
recombinant protein were pooled, dialyzed overnight against 100 mM NaCl2, 10 mM
Tris, pH 8, and concentrated with a Centriplus centrifugal filter (Millipore; Billerica, MA).
Protein concentrations were determined using a BCA Protein Assay Kit per
manufacturer’s instructions (Pierce; Rockford, IL). Nickel affinity purified rMsADAM was
provided to Proteintech Group Incorporated (Chicago, IL) for polyclonal antibody
production in two rabbits. Total IgG antibodies were purified from the rabbit preimmunization bleed and final bleed sera according to the manufacturer’s protocol for
Immobilized Protein A/G Agarose (Pierce; Rockford, IL). The animal protocol for
antibody production was reviewed and approved by the University Committee on Animal
Care at the James H. Quillen College of Medicine, East Tennessee State University.

Western Analyses of Spore Protein
E. cuniculi and E. intestinalis spore proteins were obtained by boiling the spores
for 15 minutes in lysis buffer (5 % SDS, 60 mM Tris-HCl pH 6.8, 10 % glycerol, and
fresh 2-mercaptoethanol added to a final concentration of 15 % (v/v)). Following
centrifugation, the resulting total protein lysate was separated by SDS-PAGE. Western
analyses were conducted using a 1:500 dilution of protein A/G purified polyclonal rabbit
antibodies against rMsADAM and a 1:2000 dilution of goat anti-rabbit alkaline
phosphatase-conjugated antibody (Southern Biotech; Birmingham, AL).

Identification of the ~143 kDa E. cuniculi Spore Protein
A sheet of nitrocellulose membrane was incubated for one hour with a 1:100
dilution of anti-rMsADAM antibodies prepared in Tris buffered saline (TBS), pH 7.4, plus
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0.05% Tween-20 (1X TBST). After blocking the membrane with 5% non-fat dry milk in
1X TBS, the membrane was incubated overnight in a solution of protein extracted from
lysed E. cuniculi spores (see Western analyses of spore proteins, above, for spore lysis
protocol). Unbound E. cuniculi proteins were removed by washing in 1X TBST. The
remaining bound E. cuniculi proteins were eluted in the presence of lysis buffer (see
lysis buffer components above). The resulting protein sample was separated by SDSPAGE. For Western analysis, membranes were incubated in a 1:500 dilution of the
anti-rMsADAM antibodies followed by a 1:2000 dilution of goat anti-rabbit alkaline
phosphatase-conjugated antibody (Southern Biotech; Birmingham, AL). BCIP and NBT
were used for detection. The corresponding E. cuniculi protein band, located at ~143
kDa on the Coomassie stained SDS-PAGE gel, was excised and sent to Midwest Bio
Services, LLC (Overland Park, KS) for mass spectrometric analysis.

Immunolabeling and Transmission Electron Microscopy
RK-13 monolayers grown in T 75 cm2 flasks were incubated with E. cuniculi or E.
intestinalis spores until numerous infectious foci were observed. Infected RK-13
monolayers were fixed for one hour with 2% paraformaldehyde, 0.05% glutaraldehyde
in 0.2 M Sorenson’s buffer. Following several washes with 0.1 M Sorenson’s buffer,
monolayers were removed by scraping and enrobed in 3% SeaKem agar. The agarenrobed pellet was washed three times with 0.1 M Sorenson’s buffer at 4C for 15
minutes. The pellet was sequentially dehydrated with 35%, 50%, and 70% methanol at
4C for five minutes and with 90% methanol at -20C for 30 minutes. The following
infiltration steps were performed for one hour each at -20C: 1:1 Lowicryl K4M
resin/90% methanol, 2:1 Lowicryl K4M resin/90% methanol, and Lowicryl K4M resin
only. The pellet was then incubated in Lowicryl K4M resin overnight at -20C. The
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pellet was embedded in Lowicryl K4M resin, and photopolymerization was carried out
for two days at -20C, two days at 4C, and at room temperature for two days.
Sections were blocked in 1% albumin and 0.01 M glycine prepared in PBS for
five minutes. These sections were then incubated with a 1:50 dilution of protein A/G
purified polyclonal rabbit antibodies against rMsADAM in blocking solution for 40
minutes at 37C and washed with PBS three times for five minutes each. Sections were
blocked again for five minutes and incubated for 30 minutes at 37C with a 1:200
dilution of AuroProbe EM 15 nm gold-labeled goat anti-rabbit IgG (H+L) (GE Healthcare;
Piscataway, NJ). Sections were washed with PBS three times for five minutes followed
by three 15 minute washes with sterile water. Sections were then counterstained with
5% uranyl acetate, washed with sterile water, and examined using a Tecnai 10
transmission electron microscope.

Spore Adherence and Infection Assays
Spore adherence assays were performed as previously described [5]. Briefly,
Vero cells were seeded onto 18 mm2 glass coverslips at a density of 1X105 cells per
well in 12 well plates with growth medium (see growth medium components above) and
grown to confluence. For inhibition studies, the recombinant proteins rMsADAM, rPRO,
rMET or rHsp70 (histidine-tagged recombinant microsporidia endoplasmic reticulumassociated heat shock protein [7,8]), and the above described polyclonal anti-rMsADAM
antibodies and anti-rHsp70 antibodies were diluted in 1mM MnCl2-supplemented growth
medium at final concentrations of 0.0001 mcg ml-1 to 1 mcg ml-1 recombinant protein or
1:100 diluted antibodies.
To measure spore adherence, the 12 well plates containing the coverslips with
Vero monolayers were placed on ice for 30 minutes. Following the incubation, the
growth medium was removed from the 12 well plates, and one ml per well of the MnCl 2supplmented media with 107 E. intestinalis spores, and either recombinant proteins or
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antibodies was added to the plates. The 12 well plates were then incubated on ice for
four hours, and coverslips were washed with PBS to remove unbound spores. The
Vero monolayers with attached spores were fixed with a 1:1 solution of
acetone:methanol for 10 minutes at room temperature, washed by covering with PBS
for five minutes and stained with 0.01% Uvitex 2B (Polysciences, Inc.; Warrington, PA)
for 10 minutes. Samples were then washed with PBS for five minutes, counterstained
with 1 mcg ml-1 4’,6-Diamidino-2-Phenylindole, Dichloride (DAPI) (Life Technologies
Corporation; Carlsbad, CA) for five minutes, washed with PBS for five minutes and
inverted onto VECTASHIELD mounting medium (Vector Laboratories; Burlingame, CA)
on microscope slides. The number of attached spores and host cell nuclei were
counted in 20 fields per coverslip at 630X (oil immersion) magnification with an
ultraviolet filter using an Olympus BH-2 fluorescent microscope. Results for adherence
are expressed as the percentage of adherent spores relative to control samples.
To measure host cell infection, spore adherence assays were performed as
described above. However, following the PBS wash to remove unbound spores, the
coverslips were placed into new 12 well plates with fresh growth medium and incubated
in 5% CO2 at 37oC for ~30 hours to allow the attached spores to infect the host cells.
Fixing, staining and counterstaining were performed as described above. The number
of infectious foci and host cell nuclei were counted in 20 fields per coverslip at 630X
magnification using an ultraviolet filter. Results for host cell infection are expressed as
percentage of infection (infectious foci per nucleus) relative to control samples.
For adherence and infection assays, experiments were performed three times
with similar results. Data from representative experiments are shown. Statistical
significance was determined using the Student’s t test and p values of <0.05 (*) and
<0.0001 (**) were considered statistically significant and are indicated. Error bars
represent standard deviation.
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Results
Identification of an ADAM Family Member in Microsporidia
Putative proteins from the E. cuniculi database were screened for motifs
potentially involved in adhesion by comparison to the Conserved Domain Database of
the National Center of Biotechnology Information [22]. One protein (ECU06_0380) was
identified as having motifs similar to both the disintegrin domain of snake venom
proteins (expect value 6e-10) and the reprolysin domains of zinc metalloproteases
(expect value 0.002). The primary structure of the protein has multiple domains that are
similar to those of known ADAM family members (Figure 3.1), including a predicted
signal peptide sequence, pro-domain, metalloprotease domain, disintegrin domain, and
a transmembrane domain. Based on these sequence similarities, the protein has been
named microsporidia ADAM (MsADAM). MsADAM differs from other ADAM family
members because it apparently lacks a recognizable cysteine-rich domain and a
cytoplasmic tail. Instead, between the disintegrin and transmembrane domains,
MsADAM has an unknown domain of approximately 76 amino acids, which has no
significant similarity to any other proteins.
Global pairwise alignment of MsADAM with other ADAM family members showed
sequence identities ranging from 15.2% (ADAM 19) to 20% (ADAM 21). When
comparing domains independently, the MsADAM disintegrin domain was most identical
to its counterparts in other ADAMs (identity ranges from 28.1% (ADAM 4) to 36.5%
(ADAMs 9 and 12)) (Figure 3.1). This higher level of identity is due in part to the
conserved cysteine residues in the disintegrin domain and suggests that MsADAM may
have a similar secondary structure and function to other ADAMs. Interestingly,
MsADAM has a five amino acid insertion in the area proposed to be the integrin-binding
region of the disintegrin domain [16]. The ability of microsporidia to bind to host cell
integrins is unknown, but studies are currently underway to determine the nature of
integrin/MsADAM interaction(s).
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Figure 3.1 Schematic Representation of the MsADAM Domains Compared to the
Consensus ADAM Domains. MsADAM shares with ADAM proteins a pro-domain,
metalloprotease domain, disintegrin domain, and transmembrane domain. The
sequence of the metalloprotease domain catalytic site and the disintegrin domain from
several ADAM family members is shown in an alignment to illustrate that MsADAM has
an apparent functional catalytic site, a conserved downstream cysteine residue
indicative of the metzincin family of metalloproteases, and conserved cysteine spacing
of the disintegrin domain. MsADAM also has a five amino acid insertion in the integrin
binding loop (shown as a double over line).
The MsADAM metalloprotease domain contains the consensus sequence of an
active endopeptidase (HEXXHXXGXXH). A methionine residue in close proximity to the
active site of the metalloprotease domain places MsADAM in the metzincin group of
endopeptidases [23]. The methionine residue in MsADAM is located seven amino acids
away from the last histidine residue of the catalytic site, whereas the distance ranges
from 14 to 23 amino acids in other ADAMs. Although enzymatic assays using
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fibronectin, gelatin, azocasein and rMsADAM have been performed, the
metalloprotease activity of MsADAM has yet to be established.
The pro-domain of an ADAM is thought to keep the endopeptidase in an inactive
state. Removal of the pro-domain by proteolytic cleavage or autocatalysis activates the
endopeptidase [24]. Some ADAMs use a cysteine-switch mechanism of inactivation in
which a non-paired cysteine residue in the pro-domain interacts with the
metalloprotease site, keeping it inactive. While these ADAMs have an odd number of
cysteines in the pro-domain region, MsADAM has an even number of closely spaced
cysteine residues, suggesting that it may not use the cysteine-switch mechanism of prodomain inactivation. The MsADAM pro-domain also lacks a recognizable furin protease
cleavage site, which is not unexpected because the E. cuniculi genome may not have a
furin-like protease gene (personal observation). MsADAM may, however, be activated
by different proteases, as proposed for other ADAMS that lack furin recognition sites. It
is also possible that MsADAM is auto-catalytically activated in a manner similar to
ADAM 28 [25].
Pairwise alignments of E. cuniculi MsADAM with three other Encephalitozoon
species showed a high level of conservation between species, with sequence identities
to E. cuniculi MsADAM ranging from 63.6% (E. intestinalis) to 66.5% (E. hellem) in
human pathogens and 65.4% (E. romaleae) in an invertebrate pathogen. Interestingly,
E. hellem and E. romaleae showed the highest level of identity, at 76.6%, among the
four species despite their distinct host organisms. The metalloprotease domain,
including the conserved active endopeptidase sequence (HEXXHXXGXXH), the
disintegrin domain, including both the cysteine residues similar to those found in other
ADAMs and the five amino acid insert not seen in other ADAMs, and cysteine residue
numbers and spacing are particularly highly conserved among the Encephalitozoon
species, suggesting that MsADAM may function similarly within these members of the
genus. In this study, we used the E. cuniculi MsADAM sequence for recombinant
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protein expression, and the spores of two Encephalitozoon species, E. cuniculi, and E.
intestinalis, to investigate the potential role of MsADAM in spore adherence and host
cell infection.

Recombinant Expression, Polyclonal Antibody Production and Western Blot Analysis of
MsADAM in Spores
To characterize the MsADAM protein, a histidine-tagged recombinant MsADAM
protein (rMsADAM) was expressed in E. coli, purified by nickel affinity chromatography,
and used to generate antiserum. DNA encoding the region from the pro-domain to the
transmembrane-domain of MsADAM (amino acids 21-527) was cloned into a histidinetagging vector, expressed in E. coli and analyzed by SDS-PAGE and Western blot
using a monoclonal anti-polyhistidine antibody. Upon induction, a protein of molecular
weight ~61 kDa was expressed (consistent with the predicted size of ~59 kDa for the
rMsADAM protein) and was specifically recognized by the anti-histidine antibody (Figure
3.2A). When rMsADAM-specific antibodies were purified from immunized rabbit serum
and used in Western analyses of total spore protein lysates from both E. cuniculi and E.
intestinalis, the anti-rMsADAM antibodies recognized proteins of ~60 kDa, which is
approximately the predicted size of the full length MsADAM protein, and an unexpected
protein species of ~143 kDa (Figure 3.2B).

Identification of The ~143 kDa Protein Recognized by Anti-rMsADAM Antibodies
To purify and identify the anti-rMsADAM-reactive ~143 kDa protein species, E.
cuniculi spore protein lysate was incubated on nitrocellulose membrane that had been
pre-incubated with the anti-rMsADAM antibodies. After washing the membrane to
remove unbound proteins, E. cuniculi proteins that remained bound to the membrane
were eluted and the resulting protein sample was separated by SDS-PAGE, Coomassie
stained, and subjected to Western analysis using the anti-rMsADAM antibodies (Figure
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Figure 3.2 Recombinant MsADAM Expression and Antibody Production. (A) Expression
of recombinant MsADAM protein. Lysates from E. coli cultures were separated by SDSPAGE and Coomassie stained (lanes 1-3) or processed for Western analysis (lanes 46) using anti-histidine antibody. Upon induction, a protein of ~61 kDa was observed
(lane 3) and recognized by the anti-histidine antibody (lane 6). The protein, rMsADAM,
was not observed in the non-induced E. coli lysate (lanes 2 and 5). Lanes 1 and 4 show
molecular weight markers. (B) Western analyses with anti-rMsADAM antibodies
revealed specificity for MsADAM and an additional protein. Lysates from E. cuniculi
(lane 2) and E. intestinalis (lane 3) were processed for Western analysis. AntirMsADAM antibodies recognize proteins of ~60 kDa and ~143 kDa from both E. cuniculi
and E. intestinalis. The E. cuniculi MsADAM protein is predicted to be ~61 kDa and ~59
kDa after signal sequence removal. Lane 1 shows molecular weight markers. (C)
Purification and identification of the ~143 kDa E. cuniculi protein. Nitrocellulose
membrane pre-incubated with anti-rMsADAM antibodies was incubated with E. cuniculi
lysate. Unbound proteins were washed away, and bound proteins were eluted. The
proteins were Coomassie stained (lane 2) or processed for Western analysis (lane 4)
using the anti-rMsADAM antibodies. As seen in lanes 2 and 4 a ~143 kDa protein was
isolated. This protein was excised from lane 2, subjected to mass spectrometric
analysis, and identified as E. cuniculi polar tube protein 3. Lanes 1 and 3 show
molecular weight markers. (D) Western analysis of spore protein using rabbit preimmune serum. Lysates from E. cuniculi (lane 2) and E. intestinalis (lane 3) were
processed for Western analysis with rabbit pre-immune serum. The serum recognized
a protein of ~143 kDa in both spore lysates, but did not recognize the rMsADAM protein
(lane 4). Lane 1 shows molecular weight markers.
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3.2C). While no protein of ~60 kDa was eluted from the membrane, perhaps due to
comparatively stronger interaction of MsADAM to the antibody-incubated membrane,
several proteins, including a protein of ~143 kDa, were recovered from the membrane
and recognized by the anti-rMsADAM antibodies. The corresponding ~143 kDa protein
band was excised from the Coomassie stained gel, subjected to mass spectrometric
analysis, and identified as E. cuniculi polar tube protein 3 (PTP3) which has a predicted
molecular weight of ~136 kDa and an apparent molecular weight of ~150 kDa upon
SDS-PAGE [26].
Subsequent reexamination of the pre-immune rabbit serum revealed that serum
from the animal used for antibody generation, collected prior to immunization with
rMsADAM, contained antibodies reactive to several E. cuniculi and E. intestinalis
proteins, including a species of ~143 kDa, but was not reactive to the rMsADAM protein
(Figure 3.2D). Microsporidia, particularly E. cuniculi, naturally infects rabbits, therefore
finding an entirely naïve rabbit for antibody production may continue to be a challenge.
In fact, Western analyses of several other pre-immune rabbit sera from the supplier
used to generate our anti-rMsADAM serum and from additional suppliers demonstrated
that the rabbits already generated antibodies that reacted to multiple E. cuniculi and E.
intestinalis proteins of various sizes (data not shown). Future generation of more
specific anti-rMsADAM antibodies will be attempted in rodents.

Localization of MsADAM in E. cuniculi and E. intestinalis Spores
To determine the location of MsADAM in spores, host cells were infected in vitro
with E. intestinalis or E. cuniculi spores, immunolabeled using either antibodies from
pre-immune serum or purified anti-rMsADAM antibodies, and examined by transmission
electron microscopy (TEM). In infected cells labeled with pre-immune antibodies, no
host cell or spore structures were labeled in either E. cuniculi infected host cells (data
58

not shown) or in E. intestinalis infected host cells (Figure 3.3). Because the pre-immune
serum antibodies failed to label spore structures, including those specifically
immunolabeled by the anti-rMsADAM antibodies, the reactivity of the pre-immune
serum demonstrated in Western analyses should not impact the TEM localizations
presented in this study. It is possible that the significant effects of detergents and
reducing agents used to generate the spore lysates for SDS-PAGE exposed protein
motifs in Western analyses that were not available for antibody binding in alternatively
manipulated samples used for TEM.

Figure 3.3 Immunolabeling of E. intestinalis and E. cuniculi Infected RK-13 Cells with
Pre-immune Serum Antibodies. Sections of E. intestinalis or E. cuniculi infected RK-13
cells were labeled with antibodies from rabbit pre-immune serum followed by 15nm
gold-labeled goat anti-rabbit secondary antibody. As seen in this representative image
of E. intestinalis infected cells, no specific labeling was observed within the major spore
structures including the polar sac (PS), anchoring disk (AD), polar tube (PT), plasma
membrane (PM), endospore (EN), and exospore (EX). No labeling occurred within
surrounding host cells, and no labeling of E. cuniculi spores was observed (data not
shown).
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In infected host cells labeled with the anti-rMsADAM antibodies, MsADAM
localizes to the bell-shaped anchoring disk/polar sac region of both E. intestinalis and E.
cuniculi spores (Figures 3.4 and 3.5). The polar sac is an electron dense structure
enclosed in a unit membrane that is closely associated with the apex of the spore. The
polar filament enters the sac and terminates in a biconvex disk shape at its center. This
region helps anchor the polar filament to the spore wall and plays a role in the rupture of
the spore wall and subsequent extrusion of the polar tube following spore activation
[27]. Immunolabeling with anti-rMsADAM antibodies specifically and consistently
localizes MsADAM expression to the flared biconvex anchoring disk region of both E.
intestinalis and E. cuniculi; while MsADAM expression is comparatively sparse in the
polar sac region of both species (Figures 3.4 and 3.5).
Outside of the anchoring disk/polar sac region, MsADAM expression in E.
cuniculi and E. intestinalis differs significantly. In E. cuniculi, MsADAM is located only in
the anchoring disk and polar sac (Figure 3.4). In E. intestinalis, however, MsADAM
localizes not only to the anchoring disk/polar sac complex, but also to the exospore and
plasma membrane (Figure 3.5). This difference in MsADAM expression is unexpected
due to the high degree of MsADAM sequence conservation among the Encephalitozoon
species. Because the E. cuniculi MsADAM sequence was used to express the protein
for generating the antibodies used in this study, low anti-rMsADAM antibody affinity for
E. cuniculi MsADAM compared to E. intestinalis MsADAM probably does not fully
explain the relatively limited MsADAM labeling observed in E. cuniculi. Thus, the
interspecific variation in MsADAM localization is of interest, and further examination of
the nature of the variation may reveal biologically important differences between
microsporidia species.
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Figure 3.4 Localization of MsADAM in E. cuniculi Spores. Sections of E. cuniculi
infected RK-13 cells were labeled with anti-rMsADAM antibodies followed by 15nm
gold-labeled goat anti-rabbit secondary antibody. (A-B) Immunolabeling was observed
within the polar sac (PS) and anchoring disk (AD) of E. cuniculi spores. (C) No
significant immunolabeling was observed in the exospore (EX), endospore (EN), or
plasma membrane (PM) of E. cuniculi spores. (D) Immunolabeling was observed within
the anchoring disk (AD) in spores with extruded polar tubes. No labeling occurred
within surrounding host cells.
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Figure 3.5 Localization of MsADAM in E. intestinalis Spores. Sections of E. intestinalis
infected RK-13 cells were labeled with anti-rMsADAM antibodies followed by 15nm
gold-labeled goat anti-rabbit secondary antibody. (A-E) Immunolabeling was observed
within the polar sac (PS), anchoring disk (AD), plasma membrane (PM), and exospore
(EX), but not endospore (EN) of E. intestinalis spores. (D) Immunolabeling was
observed within the anchoring disk (AD) in spores with extruded polar tubes. No
labeling occurred within surrounding host cells.
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Spore Adherence and Host Cell Infection Assays
To evaluate potential involvement of MsADAM in the adherence and infection
process, a series of in vitro assays were performed to determine if the MsADAM protein,
individual MsADAM domains, or anti-MsADAM antibodies could be used to manipulate
spore adherence and host cell infection. In addition to the nearly full-length rMsADAM
protein, which lacks only the signal sequence and transmembrane domains and was
used for antibody production, we expressed two individual domains of the E. cuniculi
MsADAM protein. rPRO consists of the pro-domain alone, while rMET consists solely
of the MsADAM metalloprotease domain (Figure 3.6). Attempts to express the
MsADAM disintegrin domain alone were unsuccessful. Microsporidia Hsp70, previously
shown to be uninvolved in spore adherence [7,28], served as the control in the spore

Figure 3.6 Recombinant MsADAM Constructs Expressed for Use in Spore Adherence
and Host Cell Infection Assays. The domains of the full-length MsADAM protein, based
on sequence analysis, are shown (MsADAM), followed by constructs used to express
multiple and individual domains of the protein for use in spore adherence and host cell
infection assays. rMsADAM, the recombinant protein used for antibody production,
lacks only the signal sequence (SS) and transmembrane (TM) domains, while rPRO
and rMET consist of only the pro-domain and metalloprotease domain, respectively. All
constructs are histidine-tagged and were expressed in E. coli.
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adherence and infection assays. Recombinant Hsp70 (rHsp70), anti-rHsp70 antibodies,
and protein diluent alone (used in protein serial dilutions) each had no effect on
adherence or infection compared to assays carried out with no additional exogenous
components (data not shown).
We have shown in previous studies that inhibiting spore adherence in vitro
reduced subsequent infection of host cells [5]. In the present study, E. cuniculi
adherence to host cells was not affected by the addition of exogenous rMsADAM to
assays of spore adherence (data not shown) and infection assays with E. cuniculi were
not conducted. In assays of E. intestinalis spore adherence to host cells, however, the
addition of either exogenous rMsADAM or rMET inhibited spore adherence to host cells
by ~20 to 30% of control adherence, while the addition of rPRO had no effect on
adherence (Figure 3.7A). Serial dilutions of rMsADAM and rMET proteins added to
spore adherence assays confirmed that these proteins exerted the observed inhibition
of E. intestinalis adherence in a dose-dependent manner (Figure 3.7B). Addition of
exogenous rMsADAM or rMET not only inhibited adherence of E. intestinalis to host
cells, but also inhibited host cell infection by ~20% in comparison to control infection
(Figure 3.7C). Addition of exogenous rPRO, which had no effect on spore adherence,
did not affect host cell infection (Figure 3.7C). When anti-rMsADAM antibodies were
added to assays of E. intestinalis adherence and infection of host cells, similar degrees
of inhibition of adherence and infection (~ 20%) were observed in comparison to control
Hsp70 antibodies, supporting the involvement of MsADAM in E. intestinalis adherence
to and infection of host cells (Figure 3.7D).
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.
Figure 3.7 Spore Adherence and Infection Assays. (A) Recombinant proteins (1 mcg
ml-1) were incubated on Vero monolayers in the presence of E. cuniculi or E. intestinalis
spores. Monolayers were washed to remove unbound spores and evaluated for
adherent spores. (B) Dilutions of rMsADAM and rMET (0.0001-1 mcg ml-1) were
incubated on Vero monolayers in the presence of E. intestinalis. Monolayers were
washed and evaluated for adherent spores. (C) Recombinant proteins (1 mcg ml-1)
were incubated on Vero monolayers in the presence of E. intestinalis. Monolayers were
washed and returned to culture to allow host cell infection then evaluated for infectious
microsporidia. (D) Anti-rHsp70and anti-rMsADAM antibodies (1:100 dilution) were
incubated on Vero monolayers in the presence of E. intestinalis. Monolayers were
evaluated for adherent spores and host cell infection. (A-D) Twenty microscopic fields
were evaluated per coverslip in each of three experiments with similar results.
Representative experiments are shown. Statistically significant differences from
controls were determined using the Student’s t test and p values of <0.05 (*) and
<0.0001 (**) were considered statistically significant and are indicated. Error bars
represent standard deviation.
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Discussion
The focus of our research is identifying host and microsporidia proteins that may
be involved in spore adherence and host cell infection. Previously, we characterized
EnP1, a ~40 kDa microsporidia protein with no homology to known proteins that may
act as a spore adherence ligand [7, 8]. We showed that EnP1 is expressed in both E.
cuniculi and E. intestinalis spores, and localizes to the polar sac/anchoring disk
complex, endospore and exospore in both species. Studies using mouse anti-EnP1
antibodies [29], suggested that EnP1 is localized only to the microsporidia endospore
and not the exospore. Nevertheless, addition of exogenous recombinant Enp1 or rabbit
anti-EnP1 antibodies to spore adherence and infection assays inhibited the adherence
of E. cuniculi and E. intestinalis to host cells and inhibited subsequent infection of these
cells, supporting the spore surface expression of EnP1 [7]. MsADAM is similar to EnP1
in that both proteins localize to the exospore of E. intestinalis and to the polar
sac/anchoring disk region of E. intestinalis and E. cuniculi spores. In contrast to EnP1,
however, MsADAM does not localize to the endospore of either Encephalitozoon
species or to the exospore of E. cuniculi. Additionally, EnP1 does not localize to the
plasma membrane in either species; while MsADAM is located in the plasma membrane
of both Encephalitozoon species. In view of these data, it is clear that the antibodies
specific to either EnP1 or MsADAM recognize unique and specific proteins.
In the present study, a novel protein with a metalloprotease catalytic site, a
disintegrin domain, and a transmembrane domain has been identified in microsporidia.
The features of this protein suggest that it is a member of the ADAM family of zinc
metalloproteinases, thus it has been named MsADAM (microsporidia ADAM). ADAM
proteins are involved in a variety of functions including adhesion and proteolysis.
Because MsADAM is found on the spore surface and in the anchoring disk complex, it
may modulate either spore proteins or host cell surface proteins during the spore
adherence and/or activation process that leads to spore germination and host cell
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infection. MsADAM lacks a recognizable cysteine-rich domain, which may be important
because the cysteine-rich domain and the disintergrin domain of ADAMs are thought to
be responsible for the physical interaction of ADAMs with other proteins and their
protease specificity [16]. In fact, crystallography studies of snake venom ADAMs have
shown that these two domains are accessible for protein-protein interaction [30]. In
place of the cysteine-rich domain, MsADAM has a notably shorter unknown domain
(~76 amino acids compared to ~190 amino acids in the cysteine-rich domain of most
ADAMs) that bears no similarity to any known functional domains. Interestingly, some
fungal ADAM family members have shortened cysteine-rich domains (Magnaporthe
grisea, accession XP_365884; Gibberella zeae, XP_391400; Aspergillus nidulans,
XP_663223), but the MsADAM unknown domain shows no significant amino acid
similarity to the shortened fungal ADAM cysteine-rich domains. The role of this unique
undefined MsADAM domain and its possible effect on the disintegrin domain, may result
in a function distinct from that of other ADAM proteins.
Previous analysis of the E. cuniculi genome suggested that microsporidia have
relatively few known peptidases; however, the presence of metallopeptidases in soluble
extracts of microsporidia spore precursor cells was suggested by proteolytic activity of
the extract toward azocasein [19]. Four protein bands, ranging in size from 50 to 76
kDa, cleaved casein in zymogram gels. Two of these proteins were identified by mass
spectrometric analysis as an aminopeptidase A and a leucine aminopeptidase. Other
studies have shown that the fungal metabolite fumagillin targets a microsporidia
methionine aminopeptidase-2 [31] and that the synthetic fumagillin analog TNP470
strongly inhibits recombinant methionine aminopeptidase [32]. MsADAM appears to be
a metallopeptidase, but, despite our repeated attempts, specific proteolytic activity for
MsADAM has not been established, even though the protein appears to have a
functional catalytic site. It is possible that proper post-translational modifications are
necessary for activity and that the recombinant MsADAM protein expressed in E. coli
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does not have these characteristics. It is also possible that MsADAM metallopeptidase
activity requires the presence of specific targets like ADAM 8, which actively cleaves the
IgE surface receptor CD23 but not TNF, which is cleaved by ADAM 17 [33].
Identifying target sequence(s) for MsADAM will be an essential part of deciphering its
function.
Our TEM data localizes MsADAM to the flared funnel-shaped anchoring disk and
the terminal polar sac of both E. intestinalis and E. cuniculi spores. The polar sac is a
bell-shaped structure enclosed in a unit membrane at the apex of the spore. The
anchoring disk is the flared biconvex terminal end of the coiled polar tube, which
terminates at and is embedded in the polar sac. MsADAM may be anchored in these
membranes via the protein’s transmembrane domain. Although the function of
MsADAM in this location is unknown, the involvement of this region in rupture of the
spore that releases the everting polar tube suggests that MsADAM, a putative protease,
may be involved in the activation process that initiates this rupture.
Importantly, the expression pattern of MsADAM in E. intestinalis is different than
in E. cuniculi. MsADAM is located only in the polar sac/anchoring disk region in E.
cuniculi. In E. intestinalis, MsADAM is located in the exospore, the plasma membrane,
and the polar sac/anchoring disk region. The expression of MsADAM on the surface of
E. intestinalis but not E. cuniculi is yet another indicator of the uniqueness E. intestinalis
within the genus. E. intestinalis was originally classified as its own genus (Septata
intestinalis) within the family Encephalitozoonidae [34] but was re-classified to the
genus Encephalitozoon based on intergenic sequence data [35]. Another attribute that
separates E. intestinalis from other species of this family is morphologic evidence of
fibrillar material surrounding mature spores inside parasitophorous vacuoles [34]. The
variation of protein expression patterns among microsporidia species gives a unique
advantage to researchers. Because we cannot genetically manipulate microsporidia,
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the observed differential localization of MsADAM in two Encephalitozoon species will be
beneficial in studying differences in the function of this protein between species.
The interspecifc variation in MsADAM expression raises interesting questions
concerning the role MsADAM may play in microsporidia adherence to and infection of
host cells. The lack of effect of exogenous rMsADAM on E. cuniculi adherence to host
cells was not unexpected, considering the observed absence of MsADAM on the
surface of E. cuniculi spores. The comparatively restricted localization of MsADAM in
E. cuniculi does not eliminate the possiblilty that this protein may play a role in host cell
infection by E. cuniculi. While surface MsADAM may act as a ligand for host cell
surface receptor(s) involved in adherence and infection in E. intestinalis, it may have a
different function in the polar sac/anchoring disc complex, where it is similarly located in
both of the Encephalitozoon species. Because the polar sac/anchoring disc complex is
involved in spore rupture and polar tube eversion, putative proteolytic activity of
MsADAM may affect events that occur independently of spore adherence, yet still have
an effect on subsequent infection of host cells.
In accordance with our demonstrated localization of MsADAM to spore surface
structures in E. intestinalis spores, we showed that the addition of exogenous rMsADAM
to spore adherence assays inhibited adherence of E. intestinals to host cells. Variation
in MsADAM expression, especially in the exospore, could impact host range, affect
prevalence, or play a role in dissemination. Interestingly, although both species of
microsporidia considered in the present study infect humans, E. intestinalis is more
commonly identified in acquired immunodeficeincy syndrome (AIDS) patients [36].
Nevertheless, any correlation of MsADAM exospore expression in E. intestinalis to
infection of humans or other animals in vivo, while intriguing, remains to be confirmed.
Exogenous rMsADAM and rMET inhibited E. intestinalis spore adherence to the
same extent. The rPRO domain, however, failed to inhibit spore adherence. These
data suggest that the metalloprotease domain of MsADAM is the component
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responsible for the observed inhibition of spore adherence and that the remaining
domains or, perhaps, the overall structure of the protein, are not required for this aspect
of MsADAM function and activity. However, examination of the MsADAM disintegrin
domain, which we were unfortunately unable to independently express and purify, would
reveal information about the role that this domain may play in microsporidia adherence
and infection, especially concerning possible interaction with host cell integrins.
Similar to our previous studies of spore and host cell determinants of adherence
and infection [5–7], the observed rMsADAM- and rMET-dependent inhibition of
adherence in the present study correlated with a decrease in subsequent host cell
infection. Thus the data presented in this study support our hypothesis that spore
adherence is an integral event in the infection of host cells by microsporidia. It is
notable that the inhibitory effect of exogenous rMsADAM (or anti-rMsADAM) on in vitro
adherence and infection was demonstrated only in microsporidia with surface
expression of MsADAM (E. intestinalis, but not E. cuniculi). A previous study
demonstrated a similar inhibitory effect of exogenous recombinant EnP1 (or anti-EnP1
antibodies) on in vitro adherence and infection in both Encephalitozoon species, in
correlation with EnP1 surface expression in both species.
As for many infectious microorganisms, the process of microsporidia adherence
and infection is complex and may involve multiple parasite and host proteins. In this
study we have identified potential microsporidia ADAM (MsADAM) proteases in E.
intestinalis and E. cuniculi. Immunoelectron microscopy of host cells infected with E.
cuniculi in vitro localizes MsADAM only to the polar sac/anchoring disk complex of E.
cuniculi spores. No evidence for involvement of MsADAM in E. cuniculi adherence and
infection was demonstrated. In contrast, immunoelectron microscopy of host cells
infected with E. intestinalis in vitro localizes MsADAM to the plasma membrane and the
exospore in addition to the polar sac-anchoring disk region of E. intestinalis spores.
Spore adherence and infection assays were used to demonstrate an inhibitory effect of
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exogenous rMsADAM on adherence and infection of E. intestinalis, but not E. cuniculi
spores. Our data thus suggest that surface MsADAM is involved in E. intestinalis
adherence and infection of host cells. Because MsADAM has the potential to act as a
metalloprotease and/or disintegrin, further studies of the protein may reveal additional
activity or interactions that affect the infection process of the Encephalitozoon species.
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Abstract
Microsporidia are obligate intracellular, spore-forming, fungal-related pathogens
which employ a unique organelle, the polar tube, to transfer infectious spore contents
into host cells to initiate infection. Microsporidia spores adhere to host cell surfaces in
vitro and it is likely that during in vivo infection, spore adherence to host cells provides
the proximity required for polar tube/host cell interaction. Determination of host cell and
spore components that participate in adherence has begun to elucidate the role spore
adherence plays in microsporidia infection of host cells in vitro. In previous in vitro
studies, the addition of exogenous sulfated glycosaminoglycans (GAGs) or spore wall
and anchoring disk complex protein EnP1 (EnP1) inhibited both spore adherence to
host cells and subsequent infection of these cells by ~60 to 90%. Complete ablation of
spore adherence and infection could not be achieved using sulfated GAGs or Enp1 as
binding competitors suggesting that additional or alternative spore and host cell
determinants of adherence and infection may exist. Analysis of the E. intestinalis
genome revealed over 50 predicted proteins containing the canonical integrin-binding
motif and one predicted protein with a motif similar to the disintegrin domain of snake
venom proteins, which are known to bind integrins. We therefore hypothesized that
host cell integrins play a role in microsporidia adherence and infection. In this study, we
demonstrated that the addition of exogenous integrin ligands or recombinant 31 or
51 integrins significantly reduced E. intestinalis spore adherence and infection of host
cells by ~60%, supporting our hypothesis and implicating these specific integrins as
putative host cell receptors for E. intestinalis spores.
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Introduction
Microsporidia are obligate intracellular, spore-forming, fungal-related pathogens
that infect a wide range of invertebrate and vertebrate animals. Of the fourteen species
of microsporidia known to infect humans, Enterocytozoon bieneusi and Encephalitozoon
intestinalis are most commonly associated with human disease [1].
Immunocompromised individuals, such as those with acquired immune deficiency
syndrome (AIDS) or those undergoing immune suppressive therapies following organ
transplants or for the treatment of rheumatoid arthritis, can exhibit severe manifestations
of microsporidiosis including chronic diarrhea, malabsorption, wasting, disseminated
disease and death [3–5]. Immunocompetent individuals also show evidence of
microsporidia infections, frequently with mild or no symptoms, suggesting that human
exposure to microsporidia may be relatively common [6–8]. Currently available
therapies for human microsporidiosis are extremely limited, and an understanding of the
events and mechanisms of the infectious process of microsporidiosis is needed to
facilitate development of safe and effective treatments for microsporidia infection.
Outside of the host, microsporidia exist as metabolically inactive, environmentally
resistant spores [1]. The spore wall of microsporidia, consisting of the chitinous
endospore and the protein-containing exospore, affords the spore rigidity and protection
and also positions spore wall proteins to interact with host cell surface molecules. It is
likely that microsporidia such as E. bieneusi and E. intestinalis are transmitted to
humans via the fecal-oral route upon the ingestion of contaminated water [5]. Not
surprisingly, given this route of infection, the initial site of infection in humans is usually
the small intestine epithelium [9]. Inside the host, spores become activated and forcibly
extrude a unique organelle, the polar tube, which may either pierce the host cell or be
taken into the cell by cellular plasma membrane invagination [10]. The infectious
material of the spore, the sporoplasm, passes through the polar tube into the cytoplasm
of the host cell. Spores proliferate within the host cells, progressing through multiple
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developmental stages before the host cells rupture. Newly released, mature spores,
can infecting nearby cells, causing disseminated infection within the host, or passing
into the environment.
Spores adhere tightly to host cell surfaces in vitro and cannot be removed by
repeated washing [11]. It is likely that during in vivo infection, spore adherence to host
cells is important to ensure the necessary proximity for polar tube/host cell interaction
and the transfer of sporoplasm into the host cell. Determination of host cell and spore
components that participate in adherence has helped clarify the role spore adherence
plays in microsporidia infection of host cells in vitro. Previously, we have shown that in
vitro spore adherence to host cells was significantly reduced by the addition of
exogenous sulfated glycosaminoglycans (GAGs) and in cells that were deficient in
surface sulfated proteoglycan expression, suggesting that endogenous cell surface
sulfated GAGs are involved in spore adherence [11].
Additionally, we showed that the microsporidia spore wall and anchoring disk
complex protein EnP1 (EnP1) is able to bind to host cells and that the addition of
exogenous recombinant EnP1, or EnP1 antibodies, significantly inhibited spore
adherence by 60% [12]. Importantly, both of these studies demonstrated that
decreased spore adherence to host cells resulted in subsequent reduction in infection of
these cells [11, 12]. These data helped shape our hypothesis that spore adherence is a
critical part of microsporidia infection of host cells. Because complete ablation of spore
adherence and infection was not achieved using exogenous sulfated GAGs or EnP1,
additional or alternative spore and host cell determinants of adherence and infection
may exist. To better understand the mechanism of microsporidia adherence to and
infection of host cells, we have focused on determining which additional host cell
surface proteins may be involved in this process.
Many pathogenic microbes including viruses, bacteria and parasites use
mammalian cell surface proteoglycans (GAG chains attached to core proteins) and
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extracellular matrix (ECM) proteins, as well as the integrins, which bind ECM proteins,
as a means for adherence to and invasion of host cells, for spreading to neighboring
cells and for dissemination within the host [13–16]. Integrins are heterodimeric, transmembrane proteins which, through their interactions with ECM and cytosolic
components carry out crucial functions in cell structure, development, adhesion,
migration, and signaling [17].
The ECM proteins that serve as ligands for integrins have additional binding sites
which allow interactions with other ECM proteins as well as with ECM carbohydrates
[18]. ECM components are widely expressed on metazoan cells and form the interstitial
matrix between cells and, via integrin attachments, anchor epithelial cells tightly to the
basement membrane which separates epithelia from tissues underneath [18]. The
human-infecting microsporidia are capable of infecting a range of animal hosts and host
cell types, as is exemplified by the ability of E. intestinalis to infect multiple hosts and to
disseminate to many organs within the human body [19, 20], so it may be inferred that
various and/or widely distributed host cell surface moieties are involved in the
microsporidia adherence and infection process.
The possible roles of host cell integrins in microsporidia spore adherence and
infection of host cells in vitro were examined in this study. Analysis of the E. intestinalis
database by comparison to the Conserved Domain Database of the National Center of
Biotechnology Information [21] revealed over 50 predicted proteins containing the
arginine-glycine-aspartic acid (RGD) amino acid sequence (the canonical integrinbinding motif) and one predicted protein (ECU06_0380) with a motif similar (expect
value 6e-10) to the disintegrin domain of snake venom proteins, which are known to
bind integrins [22, 23]. Consequently, host cell integrins were hypothesized to be
involved in microsporidia adherence and infection of host cells, and the addition of
exogenous integrins or integrin ligands to in vitro adherence and infection assays was
hypothesized to inhibit spore adherence/infection. Data confirm that addition of
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exogenous ECM integrin ligands or recombinant 31 or 51 integrins to assays of E.
intestinalis adherence and infection significantly reduced spore adherence and infection
of host cells, supporting our hypothesis.

Materials and Methods
Host Cell Cultivation
Adherent host cell lines including African green monkey kidney cells (Vero;
ATCC CCL-81), Chinese hamster ovary cells (CHO-K1; ATCC CCL-61), and mutant
Chinese hamster ovary cells deficient in heparan sulfate synthesis (CHO PgsD-677;
ATCC CRL-2244) or deficient in glycosaminoglycan synthesis (CHO PgsA-745; ATCC
CRL-2242) were used for microsporidia cultivation and/or spore adherence and host cell
infection assays. The cell lines were cultivated as previously described [24] at 37oC and
5% CO2 in culture medium consisting of Dulbecco’s modified Eagle’s medium
(BioWhittaker; Walkersville, MD) supplemented with 2mM L-glutamine, 100U ml-1
penicillin, 100U ml-1 streptomycin, 0.25 mcg ml-1 Amphotericin B and 10% fetal bovine
serum (FBS). Vero cells, but not CHO-K1 or the corresponding mutant cell lines, were
maintained in the above culture media with 2% FBS, instead of 10% FBS.

Microsporidia Propagation and Purification
Encephalitozoon intestinalis spores were propagated in Vero cells as previously
described [24]. Briefly, cultures were maintained at 37oC in 5% CO2 in culture medium
supplemented with 2% FBS. Subconfluent Vero monolayers grown in 75 cm 2 tissue
culture flasks were incubated with spores for 10-12 days with culture medium replaced
as necessary.

After collection of infected host cells debris in culture medium, spores

were harvested by centrifugation at 3500 RPM (10 minutes) and purified from the host
cell debris by washing with 0.25% sodium dodecyl sulfate (SDS) and several washes in
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sterile water. Spores stocks were counted using a hemacytometer and stored in sterile
water at 4C.

Spore Adherence Assay
Spore adherence assays were performed as previously described [11], with the
addition of exogenous protein or antibodies to the assay as putative inhibitors of spore
adherence. Briefly, host cells were seeded onto 18 mm2 glass coverslips, at 1X105 cells
per well density, in 12 well plates with 2% FBS-supplemented culture media and grown
to ~95% confluence. To measure spore adherence, the 12 well plates containing the
coverslips with Vero monolayers were incubated on ice for 30 minutes. Following this
incubation, the culture medium was aspirated from the 12 well plates, and 10 7 spores
per well in 1 mM MnCl2-supplmented culture media (MnCl2 supplementation increases
spore adherence [11]) was added to the plates. The 12 well plates were then incubated
on ice for four hours, and coverslips were washed by dunking 10X in phosphate buffer
pH 7.4 (PBS) to remove unbound spores.
The host cell monolayers with attached spores were fixed with a 1:1 solution of
acetone:methanol for 10 minutes at room temperature, washed by covering with PBS
for five minutes and stained with 0.01% Uvitex 2B (Polysciences, Inc.; Warrington, PA)
for 10 minutes. The cells were then washed with PBS for five minutes, counterstained
with 1 mcg ml-1 4’,6-Diamidino-2-Phenylindole, Dichloride (DAPI) (Life Technologies
Corporation; Carlsbad, CA) for 5 minutes, washed with PBS for five minutes and
inverted onto VECTASHIELD mounting medium (Vector Laboratories; Burlingame, CA)
on microscope slides. The number of attached spores and host cell nuclei were
counted at 630X (oil immersion) magnification with an ultraviolet filter using an Olympus
BH-2 fluorescent microscope. Results for adherence assays are expressed as the
percentage of adherent spores relative to control samples.
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To evaluate the effect of exogenous integrin ligands on spore adherence to Vero
cells, the extracellular matrix (ECM) proteins type 1 collagen (Southern Biotech;
Birmingham, AL; product # 1200-03), laminin (BD Biosciences; San Jose, CA; product #
354232), plasma-derived fibronectin (Sigma-Aldrich; St. Louis, MO; product # F1141)
and plasma-derived vitronectin (Sigma-Aldrich; product # V8379), the control protein
bovine serum albumin (BSA; Sigma-Aldrich; product # A-7030), or cyclical RGD or RAD
peptides (Peptides International; Louisville, KY; product # ICA-4304-V and product #
PCA-3618-P1) were diluted in PBS (0.0001 to10 mcg ml-1 concentrations) and preincubated with the host cells before spore adherence assays were performed. After the
plates and cells were incubated on ice 30 minutes, the culture medium was aspirated,
the cells were washed with PBS, and the proteins in PBS (or PBS alone, as a control)
were incubated on the cells, on ice, for one hour. After pre-incubation, the PBS with
proteins was aspirated from the cells, and spores in MnCl2-supplemented culture media
were incubated on the cells as described above.
To determine the effect of combined exogenous ECM proteins, as well as the
effect of ECM pre-incubation in conjunction with the addition of exogenous
glycosaminoglycan (chondroitin sulfate A (CSA); Sigma-Aldrich; product # C-8529)
during spore adherence assays, collagen, laminin, fibronectin and vitronectin were
combined at a concentration of 1 mcg ml-1 each (4 mcg ml-1 total protein concentration;
combined ECM) in PBS and used for the one hour pre-treatment both with and without
the addition of 10 mg ml-1 CSA to the spores in MnCl2-supplemented culture media for
adherence assays as described above. Control and CSA-only samples were pretreated with PBS alone, before spore adherence assays with and without added CSA
were performed.
To compare the effect of exogenous combined ECM proteins and RGD and RAD
peptides on spore adherence in cell lines with differing cell surface glycosaminoglycan
expression, CHO-K1, CHO pgsD-677 (deficient in heparan sulfate synthesis) and CHO
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pgsA-745 cells (deficient in glycosaminoglycan synthesis) were used in spore
adherence assays as described above. Due to CHO cell sensitivity to cold, PBS preincubation and MnCl2 supplementation, the spore adherence assay was modified, for
these three cell lines only, as follows: incubations were carried out at room temperature,
proteins and peptides were diluted in serum-free culture media for pre-incubation of
cells (pre-incubation with serum free media alone was used for control samples), and
MnCl2 was not added to the 2% FBS-supplemented culture media for spore incubation
on host cells.
The effect of anti-integrin antibodies on spore adherence to Vero cells was
evaluated by pre-incubation of the cells (one hour, on ice) with antibodies to 1-6, v or
1-5 integrin chains (Millipore; Billerica, MA; product # ECM430 and product # ECM440)
diluted in 2% FBS-supplemented culture medium to 5 or 20 mcg ml-1 final concentration.
After pre-treatment, the medium with antibodies was aspirated from the cells, and
spores in MnCl2-supplemented culture medium were incubated on the cells as
described above. The effect of exogenous recombinant human integrins on spore
adherence to Vero cells was evaluated by including 5 or 20 mcg ml-1 final concentration
PBS-diluted recombinant 31 integrin, 51 integrin, 64 integrin (R&D Systems;
Minneapolis, MN; product # 2840-A3-050, product # 3230-A5-050 and product # 5497A6-050) or PBS alone, as a control, in the spores/MnCl2-supplemented culture medium
for adherence assays as described above. The Vero cells for the recombinant integrin
spore adherence assays were not pre-incubated prior to the incubation of spores on the
cells, because the recombinant integrins were included in the spores/MnCl2supplemented culture medium.

Host Cell Infection Assay
To measure host cell infection, spore adherence assays with putative inhibitors of
spore adherence were performed as described above. However, following the PBS
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wash to remove unbound spores, the coverslips were placed into new 12 well plates
with fresh culture medium and incubated with 5% CO2 at 37oC for ~30 hours to allow
the attached spores to infect the host cells. Following incubation for infection, fixation,
staining and counterstaining were performed as described for adherence assays above.
The number of infectious foci and host cell nuclei were counted at 630X (oil immersion)
magnification with an ultraviolet filter. Results for infection assays are expressed as
percentage of host cell infection (infectious foci per nucleus) relative to control samples.

Statistical Analysis
For adherence and infection assays, 20 microscopic fields were evaluated per
coverslip. Experiments were performed three times with similar results. Representative
experiments are shown. Statistically significant differences from controls were
determined using the Student’s t test and p values of <0.05 (*) and <0.0001 (**) were
considered statistically significant. Error bars represent standard deviation.

Results
Exogenous Extracellular Matrix Proteins and an RGD Peptide Inhibit Spore Adherence
and Host Cell Infection
Previous studies indicate that while up to 85% of microsporidia spore adherence
to host cells can be inhibited by the addition of sulfated GAGs in a spore adherence
assay, at least 15% of spores still adhere to host cells and lead to subsequent host cell
infection under these conditions [11]. This suggests that sulfated GAG-mediated
adherence to host cells is not the only mechanism of adherence microsporidia employ
in the infectious process. A spore adherence and infection assay developed in our lab
[11] was used to evaluate the possible role of integrins in Encephalitozoon intestinalis
adherence to Vero host cells (an adherent African green monkey-derived cell line). The
ECM proteins used as integrin ligands, and thus potential inhibitors of spore adherence,
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include collagen, laminin, fibronectin, and vitronectin and have been shown to directly
bind integrins [25].
Host cell pre-incubation with 1 mcg ml-1 collagen, laminin, fibronectin or
vitronectin prior to addition of E. intestinalis spores significantly inhibited spore
adherence to host cells by ~35% of control adherence (Figure 4.1A). When cells pre-

Figure 4.1 Exogenous Extracellular Matrix Proteins Inhibit E. intestinalis Adherence and
Infection of Host Cells. (A) Vero monolayers were pre-incubated with 1 mcg ml-1 of the
extracellular matrix proteins collagen, laminin, fibronectin or vitronectin in PBS, or PBS
alone prior to addition of E. intestinalis spores, washed to remove unbound spores and
evaluated for adherent spores. (B) Vero monolayers were pre-incubated with 1 mcg
ml-1 of each extracellular matrix protein in PBS, or PBS alone prior to addition of E.
intestinalis spores, washed to remove unbound spores, returned to culture to allow
subsequent infection and evaluated for infected host cells. (C) Vero monolayers were
pre-incubated with 1 mcg ml-1 of bovine serum albumin (BSA) in PBS, or PBS alone
prior to the addition of E. intestinalis spores, washed to remove unbound spores and
evaluated for adherent spores. (D) Vero monolayers were pre-incubated with 1 mcg
ml-1 of BSA in PBS, or PBS alone prior to the addition of E. intestinalis spores, washed
to remove unbound spores, returned to culture to allow subsequent infection and
evaluated for infected host cells. (A-D) Statistically significant differences from controls
were determined using the Student’s t test and p values of <0.05 (*) and <0.0001 (**)
were considered statistically significant and are indicated. Error bars represent
standard deviation.
incubated with these ECMs and inoculated with E. intestinalis spores were further
incubated to allow infection, host cell infection was similarly significantly reduced by
~30% of control infection (Figure 4.1B). Confirming that the inhibition caused by the
addition of exogenous ECMs is specific, 1 mcg ml-1 bovine serum albumin (BSA) pre-
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incubation of host cells prior to assay of E. intestinalis adherence and infection had no
effect on spore adherence or subsequent host cell infection (Figures 4.1C and 4.1D).
Pre-incubation of cells with serial dilutions of ECMs demonstrated that ECM-dependent
inhibition of spore adherence to host cells is dose-dependent up to 1 mcg ml-1 (Figure
4.2). Pre-incubation of cells with higher concentrations of ECM proteins up to 10 mcg
ml-1 did not result in further increased inhibition of adherence or infection (data not
shown).

Figure 4.2 Extracellular Matrix Protein-dependent Inhibition of E. intestinalis Adherence
is Dose-dependent. Vero monolayers were pre-incubated with serially diluted
extracellular matrix proteins collagen, laminin, fibronectin or vitronectin in PBS (0.0001
to 1 mcg ml-1 final concentrations), or PBS alone prior to addition of E. intestinalis
spores, washed to remove unbound spores and evaluated for adherent spores.
Statistically significant differences from controls were determined using the Student’s t
test and p values of <0.05 (*) and <0.0001 (**) were considered statistically significant
and are indicated. Error bars represent standard deviation.
Because each ECM evaluated contains the canonical integrin-binding arginineglycine-aspartic acid RGD amino acid sequence [18] and over 50 predicted E.
intestinalis proteins contain this sequence, interaction of the RGD sequence of E.
intestinalis spores with a host cell surface moiety is plausible. Short RGD-containing
peptides have been shown to inhibit cell adherence to collagen, laminin, fibronectin, or
vitronectin-coated culture plates [26] and to interact directly with integrins [18]. To
determine if the RGD sequence alone can modulate spore adherence to host cells, cells
were pre-incubated with a short RDG-containing peptide prior to assays of E. intestinalis
adherence and infection.
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Host cell pre-incubation with the RGD peptide, but not a control RAD peptide,
significantly inhibited spore adherence to host cells in a dose-dependent manner, with
inhibition of ~40% of control adherence at 10 mcg ml-1 peptide concentration (Figure
4.3A). When cells pre-incubated with the RGD or RAD peptides were assayed for
infection, host cell infection was significantly reduced by ~20% of control infection with
10 mcg ml-1 RGD pre-incubation, while RAD pre-incubation had no effect on infection
(Figure 4.3B). In vitro Inhibition of E. intestinalis adherence and infection of cells by preincubation of the cells with known integrin ligands, including both ECM protein ligands
and the RGD peptide, supports our hypothesis that integrins are involved in
microsporidia adherence and infection of host cells.

Figure 4.3 RGD Peptide Inhibits E. intestinalis Adherence and Infection of Host Cells.
(A) Vero monolayers were pre-incubated with serially diluted RGD or RAD peptides in
PBS (0.001 to 10 mcg ml-1 final concentrations), or PBS alone prior to addition of E.
intestinalis spores, washed to remove unbound spores and evaluated for adherent
spores. (B) Vero monolayers were pre-incubated with 10 mcg ml-1 of RGD or RAD
peptides in PBS, or PBS alone prior to addition of E. intestinalis spores, washed to
remove unbound spores, returned to culture to allow subsequent infection and
evaluated for infected host cells. (A-B) Statistically significant differences from controls
were determined using the Student’s t test and p values of <0.05 (*) and <0.0001 (**)
were considered statistically significant and are indicated. Error bars represent
standard deviation.
Combined ECM proteins do not further inhibit adherence and infection compared to
individual ECM proteins
The approximately equivalent inhibition of E. intestinalis adherence to and
infection of host cells (~35% and ~30%, respectively; Figures 4.1A and 4.1B) by 1 mcg
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ml-1 of the individual ECM proteins evaluated suggested that these proteins might be
operating via a common mechanism to elicit the observed effect on spore
adherence/infection. To determine if the ECM proteins act via a common mechanism or
via discrete mechanisms, combined ECM proteins were used to pre-incubate cells prior
to assays of adherence and infection. Pre-incubation of cells with a combination of 1
mcg ml-1 each of collagen, laminin, fibronectin and vitronectin (4 mcg ml -1 total ECM
proteins) significantly inhibited subsequent E. intestinalis adherence to and infection of
host cells by ~40% and ~30%, respectively (Figures 4.4A and 4.4B). The failure of

Figure 4.4 Combined Extracellular Matrix Proteins, Alone or with Glycosaminoglycan,
Fail to Further Inhibit Adherence and Infection. (A) Vero monolayers were preincubated with the combined extracellular matrix proteins collagen, laminin, fibronectin
or vitronectin in PBS (1 mcg ml-1 final concentrations of each ECM, 4 mcg ml-1 final
concentration of total ECMs; combined ECM), or PBS alone. After pre-incubation,
addition of E. intestinalis spores was carried out in the presence or absence of 10 mg
ml-1 CSA. Monolayers were washed to remove unbound spores and evaluated for
adherent spores. (B) Vero monolayers were pre-incubated with the combined ECM in
PBS, or PBS alone. After pre-incubation, addition of E. intestinalis spores was carried
out in the presence or absence of 10 mg ml-1 CSA. Monolayers were washed, returned
to culture to allow subsequent infection and evaluated for infected host cells. (A-B)
Statistically significant differences from controls were determined using the Student’s t
test and p values of <0.05 (*) and <0.0001 (**) were considered statistically significant
and are indicated. Error bars represent standard deviation.
multiple, combined ECM proteins to inhibit spore adherence and infection to a greater
extent than the individual ECM proteins alone, suggests that these proteins act with
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redundancy via a common mechanism, as opposed to exhibiting additive or synergistic
effects which would suggest non-redundant activity via different mechanisms.

Pre-incubation of Cells with ECM Proteins Prior to GAG-dependent Inhibition of
Adherence and Infection does Not Further Decrease Adherence or Infection
Previous studies indicate that in assays of spore adherence and host cell
infection, the addition of exogenous sulfated GAGs concomitantly with spores during
spore adherence to host cells significantly inhibits both spore adherence to and infection
of host cells [11]. Cells were pre-incubated with combined ECM proteins prior to assays
of E. intestinalis adherence carried out in the presence of the exogenous sulfated GAG
chondroitin sulfate A (CSA) to determine if ECM pre-incubation has an effect on sulfated
GAG-dependent inhibition of adherence and infection. The concomitant addition of 10
mg ml-1 CSA with addition of spores to host cells significantly inhibited adherence by
~60% of control adherence and significantly inhibited host cell infection by ~40% of
control infection (Figures 4.4A and 4.4B). Pre-incubation of cells with combined ECM
proteins prior to spore adherence and infection assays with CSA did not increase
inhibition of adherence or infection of host cells compared to control pre-incubation
alone prior to the addition of spores and CSA (Figures 4.4A and 4.4B). These data
suggest that the known sulfated GAG-mediated spore interaction with host cells and the
ECM-mediated effect on spore adherence and infection demonstrated in this study may
exert their effects via a single, perhaps complex and multi-component, mechanism.

ECM Proteins and the RGD Peptide do Not Inhibit Encephalitozoon intestinalis
Adherence to Glycosaminoglycan-deficient Cells
In interesting examples of pathogen/host cell surface interaction, several invasive
bacterial species, including Yersina, Neisseria and Helicobacter species, are capable of
recruiting host sulfated GAGs. These bacterially-recruited GAGs then facilitate the
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interaction of the GAG/bacteria complex with host cell surface vitronectin or fibronectin
resulting in augmented bacterial adherence to host cells [27]. A series of assays was
conducted to determine if the herein observed ECM-dependent inhibition of spore
adherence and infection of host cells is dependent on host cell glycosaminoglycan
composition. CHO-K1 cells (an adherent Chinese hamster ovary-derived cell line),
CHO PgsD-677cells (CHO mutant, deficient in heparan sulfate synthesis) and CHO
PgsA-745 (CHO mutant, deficient in all glycosaminoglycan synthesis) [28,29] were preincubated with the combined ECM proteins, RGD peptide or RAD peptide prior to
addition of E. intestinalis spores. The combined ECM proteins and RGD peptide, but
not RAD peptide, significantly inhibited spore adherence to CHO-K1 cells, inhibiting
adherence by ~40% and ~30%, respectively (Figure 4.5). Combined ECM proteins,

Figure 4.5 Extracellular Matrix Proteins and RGD Peptide do Not Inhibit E.
intestinalis Adherence to Glycosaminoglycan-deficient Cells. CHO-K1, CHO PgsD-677
(deficient in heparan sulfate synthesis) and CHO PgsA-745 (deficient in
glycosaminoglycan synthesis) monolayers were pre-incubated with the combined
extracellular matrix proteins collagen, laminin, fibronectin or vitronectin in serum free
culture medium (1 mcg ml-1 final concentrations of each ECM, 4 mcg ml-1 final
concentration of total ECMs; combined ECM), RGD or RAD peptides in serum free
culture medium (10 mcg ml-1) or serum free culture medium alone prior to addition of E.
intestinalis spores, washed to remove unbound spores and evaluated for adherent
spores. Statistically significant differences from controls were determined using the
Student’s t test and p values of <0.05 (*) and <0.0001 (**) were considered statistically
significant and are indicated. Error bars represent standard deviation.
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RDG peptide or RAD peptide, however, failed to inhibit spore adherence to heparan
sulfate-deficient CHO PgsD-677 cells or GAG-deficient CHO PdsA-745 cells (Figure
4.5). The effect of ECM proteins or RGD and RAD peptides on CHO-K1 or mutant CHO
host cell infection was not determined. These data indicate that the herein described
ECM protein- and RGD peptide-dependent inhibition of E. intestinalis adherence to
monkey-derived Vero cells also occurs in hamster-derived CHO-K1 cells which produce
both heparan sulfate and chondroitin sulfate. The same effect cannot be observed in
CHO mutants deficient in glycosaminoglycan synthesis, which suggests that in at least
some cell lines, exogenous ECM protein and RGD-dependent inhibition of adherence is
also GAG-dependent.

Specific Integrin Antibodies and Recombinant Integrins Inhibit Spore Adherence and
Host Cell Infection
The integrin ligand ECM proteins used in this study can directly interact not only
with integrins, but also with other protein and carbohydrate components of the ECM as
well [18]. Thus, the inhibition of spore adherence and infection by the addition of
exogenous integrin binding partners to adherence/infection assays suggests host cell
integrins are involved in spore adherence in vitro, but does not demonstrate that the
exogenous ligands are interacting directly with integrins to exert the observed effects.
Data generated using commercially available  and  integrin-mediated cell adhesion
arrays (Chemicon (Millipore), per manufacturer’s instructions) indicated that the Vero
cells used for spore adherence and infection assays in this study consistently bound
anti-3, 5, 1 or 2 integrin chain antibody-coated microplate wells, variably and
poorly bound anti-4 integrin chain antibody-coated wells, and failed to bind wells
coated with other anti-integrin chain antibodies (data not shown). This indicates that 3,
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5, 1, 2 and possibly 4 integrin chains are expressed on the host cells used in our
assays.
To more directly examine the possible role of host cell integrins in spore
adherence and infection, Vero host cells were pre-incubated with 5 or 20 mcg ml-1
commercially available (Chemicon (Millipore)) monoclonal, function-blocking antibodies
against human 1-6, v, or 1-5 integrin chains prior to assays of E. intestinalis
adherence and infection. Pre-incubation with 20 mcg ml-1 anti-3, 5, 1 or 2 integrin
chain antibodies only, but not the remaining antibodies, significantly inhibited spore
adherence to host cells by ~30% of control adherence (Figure 4.6A). Adherence
assays performed after similar pre-incubation of host cells with 5 mcg ml-1 anti-integrin
chain antibodies showed similar results without significantly less inhibition of adherence
(data not shown), and possible dose-dependence of the inhibition of adherence was
not further evaluated. Host cell pre-incubation with antibodies against 3, 5, 1 and
2 integrin chains also significantly inhibited infection of host cells by ~20% of control
infection, while the remaining anti-integrin chain antibodies had no effect on infection
(Figure 4.6B). The inhibition of spore adherence/infection of host cells by specific antiintegrin chain antibodies provides further, more direct support for our hypothesis that
host cell integrins are involved in microsporidia adherence and infection of host cells.
Assays were conducted to determine if the addition of exogenous recombinant
human 31, 51, or 64 integrins concomitantly with E. intestinalis spores during
adherence/infection assays modulates spore adherence to and/or infection of host cells.
The addition of 31 or 51 integrins to adherence assays significantly inhibited spore
adherence by ~60% of control adherence (Figure 4.7A) and similarly inhibited host cell
infection by ~60% of control infection (Figure 4.7B). The addition of 64 integrin,
which based on previously performed  and  integrin-mediated cell adhesion arrays is
not expressed on Vero host cells, to the described adherence and infection assays had
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Figure 4.6 Specific Anti-integrin Antibodies Inhibit E. intestinalis Adherence and
Infection. (A) Vero monolayers were pre-incubated with 20 mcg ml-1 anti-integrin
antibodies in 2% FBS-supplemented culture medium, or culture medium alone prior to
addition of E. intestinalis spores, washed to remove unbound spores and evaluated for
adherent spores. (B) Vero monolayers were pre-incubated with 5 mcg ml-1 anti-integrin
antibodies in 2% FBS-supplemented culture medium, or culture medium alone prior to
addition of E. intestinalis spores, washed to remove unbound spores, further cultured to
allow infection and evaluated for infection of host cells. (A-B) Statistically significant
differences from controls were determined using the Student’s t test and p values of
<0.05 (*) and <0.0001 (**) were considered statistically significant and are indicated.
Error bars represent standard deviation.
no effect on spore adherence to or infection of host cells, as expected (Figures 4.7C
and 4.7D). In vitro inhibition of E. intestinalis adherence and infection of cells by the
addition of exogenous 31 or 51 integrins supports our hypothesis that integrins are
involved in microsporidia adherence and infection and specifically implicates these
integrins as putative host cell receptors for E. intestinalis spores. Additionally, since the
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observed experimental inhibition of spore adherence in this study resulted in a
correlating reduction in subsequent host cell infection, the data presented herein also
support our hypothesis that spore adherence is a critical element in microsporidia host
cell infection.

Figure 4.7 Specific Exogenous Recombinant Integrins Inhibit E. intestinalis Adherence
and Infection. (A) PBS-diluted recombinant integrins (5 mcg ml-1) in culture medium or
PBS/culture medium alone was included during addition of spores to Vero cells. The
cells were washed to remove unbound spores and evaluated for adherent spores. (B)
PBS-diluted recombinant integrins (5 mcg ml-1) in culture medium or PBS/culture
medium alone was included during addition of spores to Vero cells. The cells were
washed to remove unbound spores, returned to culture to allow subsequent infection
and evaluated for infected host cells. (C) PBS-diluted recombinant integrin (5 mcg ml-1)
in culture medium or PBS/culture medium alone was included during addition of spores
to Vero cells. The cells were washed to remove unbound spores and evaluated for
adherent spores. (D) PBS-diluted recombinant integrin (5 mcg ml-1) in culture medium
or PBS/culture medium alone was included during addition of spores to Vero cells. The
cells were washed to remove unbound spores, incubated to allow subsequent infection
of host cells and evaluated for host cell infection. (A-D) Statistically significant
differences from controls were determined using the Student’s t test and p values of
<0.05 (*) and <0.0001 (**) were considered statistically significant and are indicated.
Error bars represent standard deviation.

Discussion
Data support our hypothesis that host cell integrins play a role in microsporidia
adherence and infection in vitro. Integrin ligands, including the ECM proteins collagen,
laminin, fibronectin and vitronectin significantly inhibited spore adherence and infection
in assays of Encephalitozoon intestinalis adherence to and infection of Vero (primate)
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host cells. These integrin ligands appear to act redundantly via a common mechanism,
because pre-incubation of host cells with a combination of these four proteins,
compared to pre-incubation with each single protein, resulted in approximately
equivalent inhibition of adherence and infection, as opposed to causing an additive or
synergistic effect, which would suggest non-redundant activity via discrete individual
mechanisms.
Because all of the ECM protein ligands used in this study share the canonical
integrin binding amino acid sequence arginine-glycine-aspartic acid (RGD) [18], as do
over 50 putative E. intestinalis proteins, we evaluated an RDG peptide as a potential
inhibitor of spore adherence and infection. Pre-incubation of cells with the RGD peptide
alone was sufficient to inhibit spore adherence and infection of host cells. It is not clear
from these assays if the ECM proteins and RGD peptide inhibit E. intestinalis adherence
to host cells by binding integrins and preventing subsequent spore/integrin interactions,
or if they operate to inhibit spore adherence via a different, unknown mechanism. It
appears possible that the observed inhibition of E. intestinalis adherence and infection
may be RGD-dependent because each RGD-containing protein and the RGD-peptide
exert a very similar effect on adherence/infection.
A previous study indicated that host cell sulfated glycosaminoglycans (GAGs) are
involved in microsporidia adherence to host cells [11]. Two experiments were
conducted to determine if sulfated GAG-dependent inhibition of E. intestinalis
adherence and infection and ECM protein-dependent inhibition of adherence/infection
might act via a common mechanism. First, Vero host cells were pre-incubated with
ECM proteins, exposed to exogenous chondroitin sulfate A (CSA; a sulfated GAG)
during spore adherence, or pre-incubated with ECM proteins and exposed to CSA
during spore adherence. Both individual treatments inhibited adherence and infection,
with CSA resulting in a higher degree of inhibition of adherence (~60% of control,
compared to ~40% of control for ECM proteins). Co-treatment with both ECM proteins
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and CSA, however, failed to result in any further inhibition of adherence beyond that
seen for CSA treatment alone. This suggests that sulfated GAGs and ECM proteins
may act via a shared mechanism to inhibit E. intestinalis adherence and infection.
Second, to determine if sulfated GAGs are required for ECM protein-dependent
inhibition of adherence, E. intestinalis adherence assays were carried out in three cells
lines concomitantly. CHO-KI cells (adherent cells of hamster origin) have normal
expression of host cell sulfated GAGs, while CHO PgsD-677 cells and CHO PgsA-745
cells are deficient in heparan sulfate synthesis and all GAG synthesis, respectively
[28,29]. ECM protein or RGD peptide pre-incubation of CHO-K1 cells both significantly
inhibited spore adherence to host cells, but pre-incubation with ECM proteins or RGD
peptide had no effect on spore adherence to CHO PgsD-677 cells or CHO PgsA-745
cells. This indicates that ECM protein- /RGD peptide-dependent inhibition of E.
intestinalis is sulfated GAG-dependent, at least in CHO cells; and thus both GAGdependent and ECM protein- /RGD peptide-dependent inhibition of spore adherence
likely operate via a shared, complex mechanism. Heparan sulfate deficiency alone or
deficiency in all GAG synthesis both eliminate the effect that ECM proteins or RGD
peptide have on E. intestinalis adherence to CHO cells, suggesting that ECM protein/RGD peptide-dependent inhibition of E. intestinalis depends largely on heparan sulfate
and not chondroitin sulfate, which is expressed in excess on CHO PgsD-677 cells
compared to CHO-K1 cells [29].
Notably, in a previous study, spore adherence to confluent CHO PgsD-677 cells
and CHO PgsA-745 cells was similarly and significantly reduced (by ~90%) compared
to confluent CHO-K1 cells, suggesting that E. intestinalis preferentially binds heparan
sulfate compared to chondroitin sulfate [11]. Multiple exogenous sulfated GAGs
including CSA, however, significantly inhibited spore adherence to host cells [11],
indicating that various sulfated GAGs might act in the same manner to reduce putative
spore interaction with host cell surface heparan sulfate. In the present study, which
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used slightly sub-confluent cell monolayers (~95% confluent), E. intestinalis adherence
to CHO PgsD-677 cells and CHO PgsA-745 cells was not significantly reduced
compared to CHO-K1 cells (data not shown); likewise, significant reduction in spore
adherence to GAG-deficient CHO cells was previously determined to depend on
complete cell confluence [11]. This suggests that different cell surface molecules are
exposed in confluent compared to sub-confluent in vitro host cell monolayers, which
may drastically affect spore adherence to these cells. In support of this idea, spores
can be microscopically observed preferentially binding to the edges of sub-confluent
cells (personal observation).
To more directly examine possible host cell integrin involvement in spore
adherence and infection, we employed antibodies to integrin  and  chains as potential
inhibitors of E. intestinalis adherence to Vero host cells. 3, 5, 1 and 2 antibodies
all inhibited spore adherence and subsequent host cell infection; additionally, these
integrin chains were determined by  and  integrin-mediated cell adhesion arrays to be
expressed on the host cells used in our assays. 2 chains do not interact with 3 or 5
chains to form integrins, and are largely expressed on leukocytes, as opposed to
epithelial cells, while 1 chains interact with 12  chains, including 3 and 5, and are
expressed on most cells in the body [18,30,31].
We thus focused on determining if 31 or 51 integrins might be involved in E.
intestinalis adherence and infection of host cells. 64 integrin was chosen as a control
because neither 6 nor 4 integrin chains were expressed on the Vero cells used in our
assays, and antibodies to these integrin chains failed to inhibit spore adherence to host
cells. When the recombinant human integrins tested were added to spore adherence
assays, concomitantly with E. intestinalis incubation on Vero host cells, 31 and 51
integrins both significantly reduced spore adherence and infection to host cells by ~60%
of control adherence and infection. 64 integrin had no effect on spore adherence or
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infection. These data support our hypothesis that host cell integrins play a role in
microsporidia adherence to and infection of host cells and suggest that 31 and/or
51 may be host cell receptors or co-receptors for E. intestinalis spores. Since either
31 or 51 integrin caused the same degree of inhibition of adherence/infection, the
1 integrin chain might be a more important participant than  chains in spore/host cell
interaction.
31and 51 integrins are biologically relevant to microsporidia infection based
on both their broad expression in humans, specifically in the intestinal epithelium [31–
38], and on the data we present here that indicate their likely importance in spore
adherence and infection of Vero host cells in vitro. Additionally, these two integrins, or
the 1 integrin chain specifically, are used directly or indirectly, by a large variety of
other viruses, bacteria and parasites for attachment and/or invasion of host cells
[36,39–46]. Some microbes such as adenovirus, which contains an RGD sequence,
and Shigella bacteria can bind directly to host cell integrins (31 and 51,
respectively) to gain access to host cells [36,47]. Other pathogens, however, such as
Streptococcus and Staphylococcus bacteria which directly interact with fibronectin, or
the apicomplexan parasite Toxoplasma gondii which directly interacts with laminin, use
host cell ECM protein integrin ligands to indirectly interact with integrins on the host cell
and achieve entry into the cell [40,41,45]. The human herpes virus HHV-8 interacts with
heparan sulfate as a binding receptor but requires interaction with 31 integrin to enter
the host cell for replication [42]. In an even more complex series of events with multiple
host cell moieties, the Neisseria gonorrhoeae bacterium interacts with host cell heparan
sulfate facilitating adherence to the host cell. The bacterium also interacts with the Nterminal end of the host cell fibronectin molecule which allows indirect interaction with
the host cell 51 integrin via the fibronectin, resulting in uptake of the bacterium by the
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host cell [46]. These examples illustrate the many possible interactions with host cell
surface moieties that can facilitate microbial adherence to and infection of host cells.
The 31 and 51 integrins, which significantly inhibited E. intestinalis spore
adherence and host cell infection when added to adherence assays, can each bind all
of the ECM protein integrin ligands evaluated [18,48–52], so the possibility remains that
the ECM proteins exerted their inhibition of adherence in an integrin-dependent manner.
It is unexpected, however that each ECM protein integrin ligand would inhibit spore
adherence to the same degree, regardless of whether multiple, distinct integrins or a
single host cell integrin were responsible for the observed reduction in adherence and
infection, because integrins show a wide range of ligand specificity and binding
preference [18]. 31, for example, preferentially binds laminin independently of the
RGD sequence, while 51 preferentially integrin binds fibronectin and other RGDcontaining ligands [18,30]. Thus, ECM protein-/RGD-dependent inhibition of E.
intestinalis adherence to host cells may operate via a mechanism distinct from that of
the observed integrin-dependent inhibition of adherence. It is also possible that ECM
proteins and the RGD peptide may act via an unknown host cell surface moiety or
moieties which interact directly or indirectly with host cell integrin(s), instead of
interacting directly with integrins via typical or alternative binding interaction. Based on
the data presented in this study, we suggest that in vitro E. intestinalis spores interact
with host cells via a complex, multi-component mechanism that involves host cell
sulfated GAGs, RGD-containing ECM protein(s), and 31 and/or 51 integrins,
perhaps similar to the Neisseria gonorrhoeae mechanism which uses heparan sulfate,
fibronectin, and the 51 integrin to gain access to host cells. In this study, because
the decrease in spore adherence achieved using the herein described molecules as
inhibitors in adherence assays correlated with a subsequent reduction in host cell
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infection, spore interaction with some or all of the putative host cell participants we have
suggested may facilitate, or even be required for infection to take place.
In summary, the addition of exogenous extracellular matrix protein integrin
ligands or recombinant 31 or 51 integrins to assays of E. intestinalis
adherence/infection significantly reduced spore adherence and infection of Vero host
cells. The data from this study support our hypotheses that integrins play a role in
microsporidia adherence and infection and that spore adherence is an important event
in the process of microsporidia host cell infection and may be required for infection to
occur.

Further studies will be carried out to determine which specific host cell and

microsporidia moieties and molecular interactions are responsible for the integrindependent effects observed in this study. Continued elucidation of the infectious
process of microsporidia may help facilitate the development of novel therapies for
microsporidiosis.
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CHAPTER 5

CONCLUSIONS

Investigating the Molecular Mechanisms of Microsporidia Infection
Microsporidia is associated with life-threatening disease in HIV/AIDS patients,
severe or disseminated disease in other immunocompromised groups, and
asymptomatic or mild disease in the immunocompetent (Didier 2005; Didier and Weiss
2011). Antiretroviral therapy (ART) has reduced opportunistic infections, including
microsporidiosis, in HIV positive individuals. However, in areas without access to ART,
microsporidiosis continues to cause substantial morbidity and mortality (Didier and
Weiss 2011; Wumba et al. 2012). Treatment options for microsporidiosis are limited,
variably effective, and associated with significant toxicity (Didier et al. 2004; Anane and
Attouchi 2010). Additionally, microsporidia infection in healthy individuals has not been
well studied, and the potential short- and long-term consequences of asymptomatic
infection have not been determined. Currently little is known about the molecular
mechanisms of microsporidia infection, but this information is essential for the
development of new effective and safe therapies for microsporidiosis.
Spores adhere firmly to host cell surfaces in vitro and are not removed by
repeated washing. During in vivo infection, spore adherence to host cells may be
required to ensure the microsporidia polar tube is sufficiently close to pierce or be taken
up by target host cells. Our laboratory has thus focused on determining specific host
cell and microsporidia spore surface participants in spore adherence in vitro. Our
previous studies have shown that: i) host cell sulfated glycosaminoglycans (GAGs) can
be used by microsporidia as receptors for adherence to host cells (Hayman et al. 2005);
ii) the microsporidia spore surface protein EnP1 binds host cells and participates in
spore adherence to host cells in a heparin binding domain-dependent manner
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(Southern et al. 2007); iii) the divalent cations manganese and magnesium augment
spore adherence to host cells, likely by activating a spore constituent (Southern, Jolly,
and Hayman 2006); and iv) in vitro inhibition of spore adherence decreases subsequent
host cell infection, while augmentation of spore adherence increases host cell infection
(Hayman et al. 2005; Southern et al. 2006; Southern et al. 2007). These studies
demonstrate the importance of microsporidia spore adherence in host cell infection and
begin to characterize the host cell and spore determinants of adherence and infection.
Complete ablation of spore adherence and infection was not achieved in these studies,
however, suggesting that additional spore and/or host cell determinants of adherence
remain to be resolved.
The goal of the research presented here is to further characterize host cell and
spore participants in microsporidia adherence and infection of host cells in vitro. The
specific aims of this research are i) to characterize an intracellular microsporidia protein
and related antibodies to use as a tool in analyses of microsporidia spore surface
proteins, ii) to identify putative microsporidia spore surface proteins that participate in
spore adherence to and infection of host cells in vitro, and iii) to examine the role of host
cell integrins in microsporidia adherence to and infection of host cells in vitro.

Hsp70 is Useful for Evaluation of Potential Spore Surface Proteins
Our first study was conducted to generate a recombinant protein and antibody
specific for an intracellular microsporidia protein to use as a control in the evaluation of
putative microsporidia spore surface proteins (Jolly et al. 2010). We examined the heat
shock protein 70 (Hsp70)-related proteins from E. cuniculi, because they are expressed
in the cytosol, endoplasmic reticulum (ER), and mitochondria of a cell (Hartl et al. 1992).
We chose a highly expressed Hsp70 family member from E. cuniculi (ECU02_0100;
‘C1’), which contains all three Hsp70 protein family signature motifs of conserved family
members, an N-terminal signal for translocation into the ER, and a C-terminal targeting
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sequence for retention in the ER (Hulo et al. 2008). We cloned and expressed the
protein C1 Hsp70 and used the purified proteins for antibody generation in rabbits.
Two-dimensional SDS-PAGE and Western analysis were used to confirm that
the purified anti-C1 Hsp70 antibodies were specific for C1 Hsp70, and immunoelectron
microscopy demonstrated an exclusively intracellular localization of C1 Hsp70 in E.
cuniculi spores. As expected, the anti-C1 Hsp70 antibodies did not inhibit E. cuniculi
spore adherence to rabbit kidney (RK-13) host cells, indicating their suitability for use in
evaluation of potential microsporidia spore surface proteins. In our second study,
neither the anti-C1 Hsp70 antibodies nor recombinant C1 Hsp70 had any effect on E.
intestinalis adherence to monkey kidney (Vero) host cells, confirming the usefulness of
this protein and antibodies to the protein for the evaluation of spore surface proteins in
both E. cuniculi and E. intestinalis spore adherence assays. Additionally, the anti-C1
Hsp70 antibodies and recombinant C1 Hsp70 did not cause detectable negative effects
on RK-13 or Vero cells (personal observation).

MsADAM Plays a Species-specific Role in Spore Adherence
Our second study was designed to identify spore surface proteins, in addition to
the previously described EnP1, that participate in in vitro spore adherence and infection
of host cells. We identified a protein (ECU06_0380) named microsporidia ADAM
(MsADAM) with domains similar to those of a disintegrin and metalloprotease (ADAM)
family glycoproteins, including a predicted signal peptide sequence, prodomain,
metalloprotease domain, disintegrin domain, and a transmembrane domain. These
domains suggested localization to the spore surface, possible protease activity, and
possible integrin binding activity. We thus characterized the localization of MsADAM
within E. cuniculi and E. intestinalis spores and, using the anti-C1 Hsp70 antibodies and
recombinant C1 Hsp70 characterized in our first study, evaluated the role of MsADAM
in spore adherence and infection of host cells.
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Immunoelectron microscopy of RK-13 cells infected in vitro with E. cuniculi and
E. intestinalis demonstrated that MsADAM localizes to the plasma membrane,
exospore, and polar sac-anchoring disk regions of E. intestinalis spores; however,
MsADAM localized only to the polar sac-anchoring disk complex of E. cuniculi spores
and was not found in the plasma membrane or exospore. This difference in MsADAM
expression was unexpected because of the substantial MsADAM sequence
conservation among the Encephalitozoon species. E. intestinalis, however, exhibits
other distinctions from E. cuniculi, including the presence of a parasite-secreted fibrillar
material within the parasitophorous vacuole, and the presence of spore wall protein 2
(Cali et al. 1993; Hayman et al. 2001; Xu et al. 2006). Thus, the spore surface
expression of MsADAM in E. intestinalis further highlights the biological difference
between E. intestinalis and E. cuniculi.
In assays of spore adherence, exogenous recombinant MsADAM protein
(rMsADAM) inhibited E. intestinalis, but not E. cuniculi, adherence to host cells,
indicating that MsADAM plays a species-specific role in E. intestinalis spore adherence.
The distribution of MsADAM within a spore thus may have an effect on microsporidia
adherence mechanisms. Spore adherence assays carried out with individual
recombinant MsADAM metalloprotease and prodomains indicated that the recombinant
metalloprotease domain alone (rMET) is sufficient to inhibit spore adherence to host
cells, suggesting that this domain is responsible for the observed MsADAM-dependent
inhibition of adherence.
Although no protease activity has been demonstrated for MsADAM, putative
protease activity may modulate either spore or host cell proteins that participate in
adherence. Because disintegrin domains are known to interact with host cell integrins,
we expected that the disintegrin domain of MsADAM might be important in spore
adherence (Zhang et al. 1998; Eto et al. 2000). We were unable to independently
express the disintegrin domain of MsADAM, however, and could not evaluate its effect
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on spore adherence. The rMsADAM- and rMET-dependent inhibition of E. intestinalis
adherence resulted in a subsequent reduction in host cell infection as expected,
providing further evidence that adherence is an important aspect in the microsporidia
infection process.
MsADAM, via metalloprotease activity, may also be important for microsporidia
functions other than adherence. ADAM metalloproteases are known to cleave ECM
proteins, such as collagen, and a wide variety of immune modulatory molecules such as
procytokines, progrowth factors, cytokine and growth factor receptors, ligands for
apoptosis, and cell adhesion molecules (Yamamoto et al. 1999). ADAM 17 and ADAM
8, for example, cleave TNF and the IgE surface receptor CD23, respectively (Fourie et
al. 2003). If MsADAM is capable of similar proteolytic activity, the protein may play a
role in ECM or immune modulation that is beneficial for microsporidia infection and
dissemination. Additionally, putative MsADAM interaction with host cell integrins via the
disintegrin domain may affect host cell signaling. Pathogenic Escherichia coli
interaction with integrin 31, for example, initiates downstream signaling that induces
cytoskeletal rearrangement that facilitates bacterial invasion of host cells (Eto et al.
2007). Integrin signaling events that involve cytoskeletal modulation could be
particularly important for microsporidia, such as E. intestinalis, that develop in
parasitophorous vacuoles within host cells.
While the data presented in our second study suggest that MsADAM, and
specifically the MsADAM metalloprotease domain play a role in E. intestinalis
adherence to and infection of host cells, we have not yet demonstrated that MsADAM
binds to integrins or other host cell surface moieties, and specific proteolytic activity of
MsADAM could not be determined. Clarification of host cell or spore binding partners or
cleavage sequences for MsADAM may be important for elucidation of the microsporidia
adherence and infection process. Site directed mutagenesis of the recombinant
MsADAM metalloprotease domain may reveal which amino acids of this domain are
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required for exogenous rMsADAM to inhibit E. intestinalis adherence to host cells.
Collectively, the demonstration of MsADAM and EnP1 participation in spore adherence
(Southern et al. 2007) suggest that microsporidia adherence to host cells is a complex
process that may comprise multiple, distinct interactions.

Host Cell Integrins Play a Role in Microsporidia Adherence and Infection
Our third study examined the role of host cell integrins in microsporidia
adherence to and infection of host cells in vitro. Analysis of the E. intestinalis genome
revealed over 50 predicted proteins with the RDG integrin-binding motif and the protein
herein named MsADAM that has a disintegrin domain. We thus hypothesized that host
cell integrins play a role in microsporidia adherence and infection of host cells. In this
study, we demonstrated that i) pretreatment of host cells with exogenous extracellular
matrix (ECM) protein integrin ligands; ii) pretreatment of host cells with a peptide
containing the RGD integrin-binding sequence; iii) pretreatment of host cells with anti3, 5, 1 or 2 antibodies; or iv) addition of exogenous recombinant 31 or 51
integrins to assays of E. intestinalis adherence/infection significantly reduced spore
adherence and infection of host cells. This supported our hypothesis and implicated
31 and/or 51 integrins specifically as putative host cell receptors for E. intestinalis
spores.
The integrin ligands collagen, laminin, fibronectin, and vitronectin appeared to act
via a single mechanism to inhibit adherence in these assays because in combination
they elicited an identical effect to that of each individual integrin ligand. Furthermore,
the RGD peptide also caused a similar degree of effect to the integrin ligands, indicating
that RGD sequences in each of these ligands may be responsible for the observed
activity. This was unexpected because it is unlikely that each ligand would interact
equivalently with a specific integrin or integrins. We originally expected that one or
more ligands would bind a specific integrin or integrins to inhibit the adherence of
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spores to host cell integrins; however, the data may indicate that integrin ligand- and
RGD-dependent inhibition of adherence and infection involves cell surface moieties
other than integrins. Alternatively, the data could indicate that an RGD-specific
interaction with the 1 integrin chain is responsible for the integrin ligand- and RGDdependent inhibition of adherence and infection.
Our data suggested that integrin ligand- and RGD-dependent inhibition of
adherence and infection may involve cell surface moieties other than integrins, and
microsporidia spores have already been determined to interact with host cell sulfated
GAGs (Hayman et al. 2005). Thus we conducted assays to determine if the addition of
exogenous sulfated GAGs to spore adherence assays and pretreatment of host cells
with integrin ligands or the RGD peptide might be inhibiting spore adherence via a
common mechanism. Our lab previously showed that the addition of exogenous
chondroitin sulfate A (CSA; a sulfated GAG) to spore adherence assays inhibited E.
intestinalis adherence and infection (Hayman et al. 2005). In this study we compared
spore adherence assays carried out on integrin ligand-pretreated cells, spore
adherence assays carried out in the presence of exogenous CSA, and spore adherence
assays carried out using cotreatment with both integrin ligands and CSA. Adding
exogenous CSA to assays caused a more robust inhibition of adherence than
pretreatment with integrins ligands. Cotreatment with both integrin ligands and CSA
failed to result in any further inhibition of adherence beyond that demonstrated for CSA
treatment alone. This suggested to us that sulfated GAGs and integrin ligands may act
via a shared mechanism to inhibit E. intestinalis adherence and infection.
Some microbes require an interaction with host cells GAGS for a subsequent
interaction with other host cell molecules such as integrins. The human herpes virus
HHV-8, for example, interacts with heparan sulfate as a binding receptor but requires
interaction with 31 integrin to enter the host cell for replication; preincubating the virus
with heparan sulfate prevented viral adherence to host cells and subsequent viral entry
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into host cells (Wang et al. 2003). To determine if sulfated GAGs are required for
integrin ligand-dependent inhibition of adherence, E. intestinalis adherence assays were
carried out in CHO-KI cells with normal expression of host cell sulfated GAGs, and CHO
PgsD-677 cells and CHO PgsA-745 cells that are deficient in heparan sulfate synthesis
and all GAG synthesis, respectively (Esko et al. 1985; Esko et al.1988). ECM protein or
RGD peptide pre-incubation of CHO-K1 cells significantly inhibited spore adherence to
host cells, but had no effect on spore adherence to CHO PgsD-677 cells or CHO PgsA745 cells. This indicates that integrin ligand- and RGD peptide-dependent inhibition of
E. intestinalis requires host cell heparan sulfate but not chondroitin sulfate, which is
expressed in excess on CHO PgsD-677 cells compared to CHO-K1 cells (Esko et
al.1988).

Proposed In Vitro Model of Microsporidia Adherence
The data presented in these studies collectively provide support for MsADAM
and host cell integrin involvement in adherence and infection and further suggests that
microsporidia adherence and infection of host cells requires more than one host cell
surface component. We propose an in vitro model in which microsporidia interacts with
host cell surface sulfated GAGs, such as heparan sulfate, 31 and/or 51 integrins,
and endogenous ECM proteins to facilitate adhesion to and infection of host cells
(Figure 5.1). To evaluate the plausibility of this model, the ability of spores to directly or
indirectly bind 31 and/or 51 integrins must be determined. This might be
accomplished in cells with normal GAG and ECM protein expression, but with
manipulated integrin expression, to remove the possibility of modulating other host cell
molecules that may be required for putative microsporidia/integrin interaction. Integrin
knock-out or knock-down in host cells could facilitate such an evaluation. Additionally,
because spore interaction with integrins may be expected to result in downstream
integrin signaling, an examination of known integrin signaling cascades in cells exposed
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to microsporidia spores, proteins, or peptides may provide evidence of microsporidia
interaction with integrins and may help clarify the role integrins play in adherence and
infection of host cells. It remains to be seen, for example, if MsADAM might interact
with host cell integrins and what implications this would have in the adherence and
infection process.

Figure 5.1 Proposed In Vitro Model of Microsporidia Adherence

The data presented in this study also support our hypothesis that spore
adherence to host cells is an integral part of subsequent infection of these cells. While
microsporidia, because of their ability to “inject” infectious sporoplasm into a host cell
via the everted polar tube, do not have the obvious requirement for entry into host cells
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that viruses, for example, have; in all cases presented here and in our previous studies
reduction of spore adherence to host cells also reduces subsequent infection (Hayman
et al. 2005; Southern et al. 2007). Although we have not provided evidence that spore
adherence is required for infection, we have showed that augmenting spore adherence
also augments spore infection, further supporting the role that adherence and infection
are intimately related.
Several lines of evidence demonstrate that while microsporidia adherence may
be required for infection, adherence alone is not sufficient to ensure host cell infection.
First, UV and chemically inactivated spores still adhere in significant numbers to host
cells but cannot cause infection (Southern et al. 2006, personal observation). Second,
while manganese and magnesium divalent cations augment both microsporidia
adherence and infection, calcium fails to augment adherence yet significantly augments
host cell infection (Southern et al. 2006). This may represent an increase in spore
germination given the role calcium is thought to play in polaroplast and posterior
vacuole swelling during germination (Pleshinger and Weidner 1985; Xu and Weiss
2005). And finally, E. intestinalis spores adhere equally well to Vero and CHO-K1 cells
but infect CHO-K1 cells at an extremely reduced efficiency compared to Vero infection
(personal observation). This indicates that despite the ubiquitous distribution of GAGs
and integrins on human cells and the likely role of these molecules in microsporidia
adherence to host cell, targets for modulation of microsporidia infection might be
manipulated to reduce or eliminate host cell infection. An understanding of the process
of microsporidia infection at the molecular level, however, will be required to exploit
specific targets that might facilitate the development of new therapies for
microsporidiosis.
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